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Abstract
Sleeping sickness is now recognized as one of the recent re-emerging but neglected
diseases. In Uganda and the rest of sub-Saharan Africa, old foci of sleeping sickness
persist despite donor-funded projects and there is evidence of expansion of these foci.
The World Health Organization acknowledges a high level of undiagnosed sleeping
sickness cases and has identified surveillance and treatment as the major control
strategy for sleeping sickness. However, to date there have been no clear
epidemiological surveillance markers applied for monitoring the burden of the disease
at control implementation levels. There is therefore a need to obtain markers for
surveillance and to apply these to monitor and improve this important strategy of
sleeping sickness control, hence, the objective of this study.
Data of sleeping sickness patients from 1987 to 2002 were collected from Tororo, Busia
and Soroti districts. Using the ratio of early to late stage patients in an affected
population, data from (Livestock Health Research Institute) LIRI hospital in Tororo
district were applied to develop a model for estimation of sleeping sickness under-
detection. The model was applied to data from a recent outbreak of sleeping sickness in
Soroti district to determine the burden of the disease. Geographical information systems
(GIS) were applied to quantify the effect of distance from the health units on early
detection of sleeping sickness. A semi-structured questionnaire was administered to
prospective sleeping sickness patients to determine their treatment seeking behavior.
Spatial and temporal trends of sleeping sickness with and without control are described
using the SatScan method for spatial temporal clustering. The potential role of remote
sensing in surveillance of sleeping sickness was explored using a processed Landsat 7
series satellite image to determine association of land cover classes, vegetation indices,
population density, distance to wetlands, distance to the sleeping sickness hospital to the
outcome of village scale disease geographical distribution generated using GIS.
In the Tororo and Busia area, for every 3 reported patients, 2 went undetected. The
Disability Adjusted Life Years (DALYs) for sleeping sickness in the Soroti outbreak
are greatly increased when under-detection is taken into account. There is a strong
effect of distance to health unit on the surveillance of sleeping sickness. Children and
xviii
adolescents are less likely to be detected in early stage. During times of low incidence,
the proportion of late stage detected patients increases. Most of the delay to diagnosis is
attributable to service provider delay and most patients are referred to the sleeping
sickness referral hospital by the community and not the health system. Proximity to
wetlands and to the sleeping sickness hospital, low population density, vegetation
wetness and smaller area of short grassland and larger area of cropland were
significantly associated with the distribution of sleeping sickness affected villages in
Tororo and Busia districts.
Surveillance of sleeping sickness can be monitored by applying the early to late stage
ratio of sleeping sickness as an epidemiological tool to determine the level of under-
detection and subsequently the burden of disease. Optimal distribution of fixed post
diagnostic units will greatly improve rhodesiense sleeping sickness surveillance.
Surveillance programmes should regularly update health workers in the primary health
care units in the vicinity of sleeping sickness affected populations. Similarly, the
affected communities can be resourcefully used to refer sleeping sickness suspects to
the appropriate health care facilities. Timely responsive disease surveillance and
intervention can prevent spread of sleeping sickness. Remotely sensed maps can assist
in accurately describing sleeping sickness foci and therefore, the area requiring
application of control interventions
xix
Chapter 1 Introduction
Diseases such as sleeping sickness are known to be re-emerging and yet have been
recognized as among the neglected diseases (Jannin et al., 2001). There have been
commendable combined public- and private-sector initiatives to tackle this neglected
disease especially in the free provision of drugs (Etchegorry et al., 2001) but a
considerable amount of effort is still required to improve the control of sleeping
sickness (Cattand et al., 2001). The economies of countries that are affected by
sleeping sickness are ranked amongst the poorest of the poor (World Bank, 2000).
Therefore, the need for cost-effective ways of control cannot be over emphasised.
The epidemiology of the disease is characterised by a focal distribution, with foci
persisting and expanding during epidemics (WHO, 1998). This focal nature has
implications on the assessment of the burden of sleeping sickness and on the
targeting of control operations to reduce costs but ensure effectiveness. Studies of
risk factors of distribution of sleeping sickness at sub-national levels are lacking and
the data obtained from such studies can be used for the planning and implementation
of control programmes. Due to the focalisation of occurrence of this disease, it is
important to describe the burden at sub-national and outbreak levels.
Good surveillance and treatment of sleeping sickness is important for planning, early
patient detection and disease control and monitoring (WHO, 1998). Specifically, for
sleeping sickness control to be rationally targeted and in order to prevent outbreaks,
the surveillance of the disease has to be improved. However, markers for
surveillance of sleeping sickness have not been well identified and applied at control
implementation level and although it is accepted that there is gross under-detection
of sleeping sickness (WHO, 2002), the exact magnitude of the problem has remained
unknown. Allocation of resources is determined by the relative burden of diseases
and therefore, good estimates of disease burden are necessary for planning. The
tsetse fly has preferable tsetse habitats and climate, and the distribution of sleeping
sickness is very much linked to the distribution of tsetse and available hosts. It is an
arduous task to determine the distribution of tsetse at high resolution levels e.g.
village or homestead levels. However, the distribution of human and livestock
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populations and infections can more easily be estimated and the distribution of tsetse
suggested by the distribution of vegetation types. Detailed analysis of the
distributions of sleeping sickness patients, land cover and other potential spatial risk
factors is now possible due to the increasing availability of powerful Geographic
Information System (GIS) software. Geographical risk analyses can therefore be
performed and strategies for targeting surveillance of sleeping sickness can thus be
designed.
1.1 Biology of sleeping sickness
Human African trypanosomiasis, also known as sleeping sickness, is a result of an
infection by blood-borne haemoflagellate protozoan parasites of two sub-species:
Trypanosoma brucei gambiense or Trypanosoma brucei rhodesiense, causing two
forms of the disease. Trypanosoma belong to the family trypanomastidae of the order
kinetoplastida. The two human infective trypanosomes belong to the subgenus,
Trypanozoon. A more chronic form of the disease is caused by T. b. gambiense and
is found in west and central Africa and an acute form caused by T. b. rhodesiense is
found in east and southern Africa (WHO, 1998). The life cycle of the parasite is
complex, involving many stages in both the tsetse fly and the mammalian host
(Figure 1.1).
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Figure 1.1. Developmental cycle of human infective trypanosome
Tiypanasanmhrucei schematic representation of developmental













(in tsetse midgut) (in mammal)
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The female tsetse fly produces a single egg, which hatches to a first stage larva in the
uterus where it develops and moults (Carpenter, 1912). A third stage larva is then
deposited on the ground. One full-grown larva is produced every 9-10 days and
pupates in light or sandy soil. A puparial period follows and an adult fly emerges in
about 30 days. The lifespan of the tsetse is three to four months. Since at least 17
days are required for the development of Trypanozoon species in the tsetse, the daily
survival rate of these flies is crucial to sleeping sickness transmission. The most
important vector responsible for the transmission of sleeping sickness in eastern
Uganda is Glossina fuscipes fuscipes (Okoth, 1986). G. f. fuscipes belongs to the
subgenus palpalis that are described as riverine tsetse. Experiments have shown that
G. f fuscipes has poor water storage and is therefore restricted to hygrophytic
habitats near water in lacustrine or riverine habitats (Jackson, 1945). Human
population and distribution of animals are important factors associated with the
distribution of the palpalis group of tsetse (Baldry, 1980). Age of fly at infective feed
has been shown to be important with younger flies being more likely to get infected
(Van Hoof et al., 1937; Wijers, 1958). However, age is apparently less critical with
G. f fuscipes and 71 b. rhodesiense with little difference in susceptibility being
observed between 2 and 11 days (Harley, 1970). The close contact of man and the
vector contact is particularly important for the transmission of sleeping sickness and
the incidence of a disease may have little relationship to the density of the tsetse
present (Page & McDonald, 1959).
For the sleeping sickness caused by 71 b. rhodesiense, the time between the bite of an
infected tsetse to the first sign of illness is usually within one to three weeks (Apted,
1970), sometimes following a trypanosomal chancre, a local inflammatory lesion at
the site of the bite (WHO, 1998). Invasion of the blood is characterized by irregular
headaches, fevers and body aches. As the disease progresses, it further invades the
lymphatics causing lymphadenopathy, and there is weight loss, rash, itching,
weakness and oedema. The sleeping patterns get distorted rather than hypersomia
(Buguet et al., (2001), giving the disease its name. 71 b. rhodesiense disease
progresses to central nervous system involvement with nervous impairment more
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rapidly (3 weeks to 2 months) (Odiit et al., 1997a) than T. b. gambiense. The patient
may have convulsions and become comatose. Clinical signs are generally non¬
specific and thus provide only a guide to diagnosis.
Trypanosomes escape the initial host defence mechanisms by antigenic variation of
parasite surface glycoproteins (Ritz, 1914). By evading the humoral immune system,
the parasite expresses its virulence and during the resulting parasitaemia,
pathological changes occur in the central nervous, cardiovascular, and
haematolymphatic systems. These pathological effects are due to immune-mediated
reactions against antigens on tissues in the affected systems, causing meningo¬
encephalitis, pancarditis, haemolysis and anaemia. Hypersensitivity reactions cause
skin manifestations such as urticaria, pruritus and oedema.
1.2 Global burden of sleeping sickness
Sleeping sickness is restricted to tropical sub-Saharan Africa (WHO, 1998). The
disease is a re-emerging problem and the World Health Organization estimates that
there are 300,000-500,000 people infected with sleeping sickness. Sixty million
people are at risk in 36 countries while only 3-4 million are under surveillance,
resulting in the reporting of only 45,000 cases per year (WHO, 2002). Amongst
infectious diseases, the burden of sleeping sickness (measured in DALYs) is ranked
highly (World Health Report, 2000). There is variation in endemic status of sleeping
sickness across countries in the tsetse belt with high incidence currently being
reported in the Democratic Republic of Congo, Angola, Sudan and Uganda (WHO,
1999b) (Figure. 1.2). Sleeping sickness and poverty are closely linked. The countries
affected by sleeping sickness rank amongst the poorest of the poor countries (World
Bank, 2000). For instance, the Gross National Product per capita for Uganda is, for
example, estimated at US $320 and the public expenditure on health at 1.8% of the
Gross Domestic Product (World Bank, 2000).
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In Uganda, gambiense sleeping sickness is found in the northwest and rhodesiense
sleeping sickness is found in the eastern parts of the country (Figure 1.3). In both
parts of the country, Glossina fuscipes fuscipes is the vector identified as responsible
for the transmission of the disease. Rhodesiense sleeping sickness (RSS) is a more
acute illness. Often the disease occurs in outbreaks and sometimes in epidemics with
loss of many of lives (Mbulamberi, 1989). However, it is acknowledged that the
basic reproductive rate, Ro, (Anderson, 1998) of trypanosomes is low (Rogers &
Williams, 1993), resulting in a disease with long periods of apparent very low
endemicity, occasionally interrupted by epidemics. Ro determines the ability of the
parasite to perpetuate itself. It is defined as the average number of new infections
produced by it throughout its life time. Ro must be greater than one for the parasite to
maintain itself. Despite the low Ro and several donor-funded projects to control
sleeping sickness in southeastern Uganda, the disease remains uncontrolled and there
is evidence of expansion of its foci (Enyaru et al., 1999; Fevre et al., 2001). Control
programmes using the current approaches are often too expensive to sustain after
donor funding has ceased. This is compounded by the fact that many governments of
the affected countries do not allocate adequate funding for sleeping sickness control
activities
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1.2.1 Burden of disease estimation: the DALY
For health policy to be effective, it requires reliable quantification of burden of
disease. The Global Burden of Disease Study (GBDS) is designed towards the
development of a rational evidence-based health policy (Murray & Lopez, 1996).
The assessment of cost-effective health interventions and prioritisation in health
policy and research can be facilitated by more accurate burden of the disease
estimates. However, one major problem in developing countries and most especially
in sub-Saharan Africa (SSA) is the lack of epidemiological and demographic data
(Kaufman et al., 1997). GBDS extrapolates epidemiological data that is available,
using cause of death models and expert judgements (Murray & Lopez, 1996). There
is therefore the need for more area and disease specific epidemiological data to
enable more accurate estimations of burden of disease (BOD). There have been
several conceptually different measures proposed for measuring BOD, such as
mortality rates, different forms of years of life lost (YLL) and the disability-adjusted
life years (DALY) that is inclusive of YLL (Gardner, 1990; Lee, 1998; Murray,
1994). The DALY is the current measure used in the GBDS. DALYs are the sum of
the present value of years lost through premature mortality, and the present value of
years of future life time adjusted for the average severity of any mental or physical
disability caused by disease or injury. Therefore, DALYs measure something 'lost'
and health programmes aim at their reduction. DALYs were first introduced in the
World Development Report (World Bank, 1993) and the Diseases Control Priorities
Review (Jamison et al., 1993) as a method for estimating the global burden of
disease as an outcome measure for use in cost-effectiveness analysis. In 1996,
another version of the DALY was developed and is currently used (Murray & Lopez,
1996).
1.3 History of sleeping sickness
Trypanosomes were first detected in man in a steamboat captain on the River
Gambia in 1901 by R. M. Forde. Forde described the clinical features in the patient
(Forde, 1902a,b) but he thought these were due to filariasis. Dutton (1902) later
identified the parasite as a trypanosome, which he described and named
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Trypanosoma gambiense. However, it was Castellani (1903a,b) and Bruce (1908)
who associated the parasite with the disease, which was already known at the time.
Again it was Castellani (1903c) who first demonstrated the parasite in the
cerebrospinal fluid. In 1908, T. b. rhodesiense was found in northern Rhodesia
(Zambia) in two Europeans who became infected in the Luangwa valley and both
died after approximately 6 months (Stephens & Fantham, 1910). The first recorded
epidemic in Uganda occurred on the shores of Lake Victoria (Christy, 1903a,b) and
is believed to have been caused by T. b. gambiense. It is suggested that the causative
agent in this outbreak may have actually been T. b. rhodesiense as was the case for
subsequent outbreaks in this area (Koerner et al., 1995). However, Gibson (1996)
disputes this suggestion. The vector identified as responsible for the epidemic was
Glossina palpalis, later defined as G. f fuscipes (Bruce & Nabarro, 1903). It is
believed that sleeping sickness had been on the northern shores of Lake Victoria
since 1896 (Christy, 1903a,b; Ford, 1971). It was estimated that more than 200,000
people died in Buganda and Busoga between 1898 and 1906. By 1905, the number of
reported patients reached 100,000 and people were evacuated to a minimum distance
of 3 km from the lakeshore and in some areas up to 24 km from the lake (Duke,
1919). Clearing of bush and treatment with atoxyl were recommended as the control
measures for sleeping sickness at the time (Koch et al., 1909).
In the early 1940s, another sleeping sickness epidemic occurred in the area
(Mackichan, 1944). By 1943, 2,432 patients were recorded with 274 deaths. The first
recorded patient was a schoolboy from Busoga detected in Kampala whilst he was
visiting. In 1941, the epidemic was shown to be due to T. b. rhodesiense. This
marked the first identification of T. b. rhodesiense in Uganda. It was concluded that
G. pallidipes was the vector of the disease in this epidemic (Duke, 1944). It was not
until 1960, that T. b. rhodesiense was detected in wild G. palpalis (G.f fuscipes) that
this fly was believed to play a role in the transmission of this parasite (Southon &
Robertson, 1961). It appeared then that T. b. gambiense had been completely
replaced by T. b. rhodesiense (Robertson & Baker, 1958). It is thought that the
source of the epidemic in the 1940s was the west side of Lake Victoria in Tanzania.
The disease persisted into the sixties perhaps because of the increased fishing activity
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as evidenced by a high male incidence compared to females (Roberston, 1963). Of
all patients between 1954 and 1960, 85% were males and there was a reduction of
patients in July and October when there was a seasonal reduction in fishing.
Before 1976, the disease appeared to be under control with only sporadic cases
presenting in the area north of Lake Victoria. However, in 1976, there was an
epidemic. Between 1976 and 1983, 19,974 sleeping sickness patients were detected.
The first reported case was detected in June 1971 north of Busesa, outside the known
G. f. fuscipes infested area, the only vector known at the time (Matovu, 1982; Abaru,
1985). The breakdown of control services associated with political turmoil as well as
the change in agricultural practices with resultant bush encroachment led to the
larger epidemic in 1976. It is believed that the epidemic spread from the old focus in
Busoga, on the shores of Lake Victoria (Gibson & Gashumba, 1983; Mbulamberi,
1989). In the early 1980s, aerial spraying of tsetse using insecticides was carried out
and it temporarily reduced the incidence of sleeping sickness (Kangwagye et al.,
1987). However, by the late 1980s, the incidence had begun to rise and the disease
spread further eastwards (Lancien, 1991; Enyaru et al., 1992) into Tororo and Busia
districts. A large tsetse trapping operation using 13,000 impregnated pyramidal tsetse
traps over an area of 39,000km2 was instituted and surveillance and treatment of both
human and cattle populations carried out (Lancien, 1991). By 1992, the number of
patients had reduced to less than 500 but has remained at an incidence of over 200
patients per year.
1.4 Diagnosis of sleeping sickness
Due to the non-specificity of the clinical features and the toxicity of the drugs, the
demonstration of the trypanosome is mandatory globally before treatment can be
administered to a sleeping sickness patient (WHO, 1998). Microscopic examination
of the blood or gland or lymph node aspirate is therefore a necessity but these
methods have low sensitivity (Cattand & de Raadt, 1991). The most common
diagnostic technique applied in the field is the stained thick smear. However, the wet
film and the haematocrit centrifugation test (Woo, 1970) are also commonly used.
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Due to the costs of staffing and equipping sleeping sickness treatment facilities, there
are few health units equipped for diagnosing and treating the disease. The problem of
poor accessibility for diagnosis and subsequently treatment may be alleviated by the
use of mobile teams. However, this is only more rewarding where a valid screening
test is commercially available. The Card Agglutination Test for Trypanosomiasis
(CATT) is such a test that has good sensitivity and specificity (Magnus et al., 1978)
but it is only useful for the T. b. gambiense sleeping sickness. A similar test for T. b.
rhodesiense is required before mobile teams can used for routine diagnosis and
treatment of this form of the disease. Since T. b. rhodesiense sleeping sickness is
more acute often causing death within 6 months of infection, a screening test would
be even more beneficial than it is in the T .b. gambiense form of the disease. In
eastern Uganda, mobile teams are used during outbreaks to increase the awareness of
the population and detect patients that may have not yet sought health care. The costs
of maintaining mobile teams are not affordable by the economies of countries
affected by sleeping sickness and therefore, they are often used in epidemic
situations and with donor support. The optimisation of the distribution of fixed post
diagnosis and treatment may be a more sustainable strategy especially in between
epidemics of sleeping sickness. Community health workers referring clinical
suspects to the fixed post diagnosis units may complement this strategy.
The detection of the trypanosome in gland or lymph node aspirate or blood is always
followed by a lumbar puncture to determine whether there is involvement of the
central nervous system (CNS) (also known as the late stage) because drugs used
when the CNS is involved are different from those used when the parasite is still
restricted to the haemato-lymphatic system (also known as the early stage) (WHO,
1998). The criteria used for determination of CNS involvement are as follows: white
blood cell counts above 5 cells/mm or the demonstration of trypanosomes or protein
levels above normal (25mg percent) in the cerebrospinal fluid (CSF). In Uganda, the
former two criteria are generally used because they are easier to perform and do not
require reagents.
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There have been attempts to determine if the criteria for treatment can be adjusted to
reduce the number of patients receiving melarsoprol treatment, which is very toxic. It
has been proposed that the number of cells to determine CNS involvement be raised
to 20 cells/mm (Doua et al., 1996). There is still not enough evidence for the change
•5
in the cut-off point for the number of cells/ mm in the CSF (Doua et al., 1996,
Miezan et al., 1998) and therefore, the WHO recommended criteria for staging are
still used.
1.5 Treatment of sleeping sickness
The costs of treatment for sleeping sickness are estimated to be more than US$ 100
per adult patient (WHO, 1998). In addition, sleeping sickness patients are almost
always from poor, rural backgrounds (Okia et al., 1994). For these reasons, it is the
policy of the government of Uganda to exempt sleeping sickness patients from cost-
sharing in health units. Currently, the broad guidelines for the treatment of sleeping
sickness in Uganda are those recommended by the World Health Organization
(WHO, 1998). Pentamidine is used for treating the early-stage of sleeping sickness
caused by T. b. gambiense but has a low efficacy for the T. b. rhodesiense sleeping
sickness. It is effective for treatment as long as there is no detectable involvement of
the central nervous system. The dosage used is 4 mg of pentamidine base per kg of
body weight. A total of 7 injections are given daily, intramuscularly. Drug resistance
appears not to be an important problem in the use of pentamidine for the treatment of
T. b. gambiense. The side effects seen include pain and induration or sterile abscess
formation at the site of injection, vomiting, abdominal pain, hypotension, syncope,
hypoglycaemia and peripheral neuritis.
Suramin is used for the treatment of the early stage of T. b. rhodesiense because
although the duration of treatment is longer than that for pentamidine and
administered intravenously, there is no primary resistance to suramin reported for T.
b. rhodesiense. It was first introduced for the treatment of sleeping sickness in 1921
(Apted, 1970). The dosage used is 20 mg/kg body weight. Intravenous injections are
given every 7 days and with a maximum of 7 injections. The side effects observed
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include pyrexia, pain in the joints and soles of the foot, skin rash and desquamation
and hypersensitivity reactions. Exfoliative dermatitis is a rare but severe adverse
reaction that may cause death as a result of total loss of skin with resultant
dehydration.
Melarsoprol (Freidheim, 1951) also known as Mel B is the drug used to treat late
stage sleeping sickness due to both T. b. rhodesiense and T. b. gambiense sleeping
sickness in Uganda. The maximum dosage for each injection is 3.6 mg/kg body
weight. Currently, two regimes for the treatment comprising several series of
injections, each separated by an interval of one week are used (WHO, 1998). One
regime starts with 2.5ml and the other with 0.5ml but both totalling to 35 mis of a 36
g/litre solution ofMelarsoprol.
The most serious side effect of melarsoprol is reactive encephalopathy often
occurring between the third injection of the first course and the beginning of the
second course. The onset may be sudden or the condition may develop slowly with
fever, headache, tremor, slurring of speech, convulsions and finally, coma. It occurs
in 5% of the patients and the incidence of fatality due to these reactions is
approximately 1% (Odiit et al., 1997a). However, the fatality of the untreated disease
is believed to be 100%, making the decision to treat an ethical necessity. The
treatment of these reactions includes the use of corticosteroids, hypertonic solutions
to combat cerebral oedema, rapidly acting anticonvulsants, and subcutaneaous
adrenaline. Other adverse reactions include diarrhoea, jaundice and dermatitis but
these conditions are generally not life threatening.
There is no recent evidence of resistance of T. b. rhodesiense to melarsoprol,
although in the early 1970s, melarsoprol treatment failure of 12 (3.4%) out of 358
treated patients was reported (Ogada, 1974). It is mandatory to follow-up
systematically all treated patients to ascertain that they have been cured. It is
recommended that patients be seen every 6 months over a two-year period (WHO,
1998). In addition to a full clinical and parasitological examination, a lumbar
puncture should be carried out on the patients; the CSF can thus be examined for any
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increase in leukocyte counts or presence of trypanosomes that would indicate that a
relapse has occurred. However, due to the painful nature of the lumbar puncture
procedure, most patients resent returning for follow-up once they have began to feel
better. Active follow-up to ensure compliance is not affordable. Therefore, less
invasive and painful methods of ascertaining cure need to be developed. It is possible
that with low treatment failure rates and lack of systematic follow-up, patients with
treatment failure may be missed. Periodic active follow-ups of cohorts of sleeping
sickness patients should be done to monitor drug efficacy.
Treatment failure for T. b. gambiense to melarsoprol is emerging. Legros et al.,
(1999a,b) report a melarsoprol treatment failure rate of 26.9% among 428 patients
treated in north-western Uganda. Legros et al. (1999b) emphasise the need for
second-line drugs to treat patients that have already received one or several full
course(s) ofmelarsoprol.
Following studies carried out on vervet monkeys (Burri et al., 1994),
pharmacokinetic data from other similar studies carried out on T. b. gambiense
patients indicated that the course of melarsoprol in an adult can be reduced from a
period of between 25 to 36 days (WHO, 1998) to just ten days, greatly cutting down
the costs of hospitalisation (Burri et al., 1995). A randomized trial comparing the
standard treatment schedule with this new concise regimen showed the same levels
of parasitological cure (100%) and adverse effects (16-17 %) as well as better
compliance with the new regime (Burri et al., 2000). The adaptation of the new
concise regime is being monitored. It would not be advisable to adapt this model to
the treatment of the late stage of T. b. rhodesiense because the pharmacokinetics may
be dissimilar given that this disease is much more severe than T. b. gambiense.
Therefore, the blood brain barrier may be more affected allowing for higher levels of
melarsoprol in the CNS and possible neurological side effects. A study of the
pharmacokinetics of melarsoprol in late stage T. b. rhodesiense infections is therefore
necessary.
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Difluoromethyl ornithine (a-DFMO) is not effective against T. b. rhodesiense (Iten
et al., 1995; Matovu et al., 1997) but is useful for the treatment of late stage T. b.
gambiense (Doua et al., 1987). It is presently available for use in Uganda for the
treatment of relapses of melarsoprol treatment. Recently, the production of this drug
has been suspended. The use of nifurtimox has been suggested where DFMO is not
available for treating melarsoprol refractory patients. This drug is very toxic but has
been reported to be effective for curing some T. b. gambiense patients including
those with late stage melarsoprol-refractory disease (WHO, 1998).
1.6 Economic importance of tsetse-transmitted African
trypanosomiasis
Tsetse-transmitted trypanosomes are important parasites for both animals and
humans in Africa. Nagana (African animal trypanosomiasis (AAT)) is a major
constraint to livestock production and affects economic development and settlement
in tropical Africa (Swallow, 2000). The important species for livestock disease are T.
congolense, T. vivax and T. brucei brucei; the latter is not easily distinguishable from
T. b. rhodesiense that affects both cattle and man (Ford, 1971) except by restriction
fragment length polymorphism (RFLP) and recently by the Serum Resistance
Antigen (SRA) gene) (Hide et al., 1994, Welburn et al, 2001) There is therefore, an
economic burden in both livestock and human populations. Animal burden tends to
be expressed in dollar terms while the relative burden of disease in humans is
measured using the Disability Adjusted Life Year (DALY) (Murray, 1994; WHO,
1999a). The DALY burden is discussed at length in Chapter 3.
1.6.1 Losses due to animal trypanosomiasis
The distribution of tsetse flies covers an area of approximately 10 million square km,
300 million people and about 50 million cattle (Budd, 1999; Kristjanson et al., 1999;
Swallow, 2000; WHO, 1999a). Generally, where the tsetse challenge is very high
such as in central Africa, the cattle density is low or cattle are not present at all
(Figure 1.4). Therefore, there are economic losses in terms of cattle exclusion and
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where there are cattle, in terms of production losses i.e. potential increases in income
in those areas currently under-used by cattle due to the trypanosome disease
constraint. It is estimated that there is US$1.3 billion lost per year in direct losses,
e.g., milk and meat off-take (Swallow, 2000). Overall agricultural production losses
are estimated to be US$5 billion (Budd, 1999). These are some of the few economic
impact studies done on livestock trypanosomiasis, which are continental level
estimates and neither adequately highlight human disease burden nor describe the
local situation at or within country level.
Figure 1.4. Map showing the distribution of cattle and tsetse in Africa
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1.6.2 Losses due to human trypanosomiasis (sleeping sickness)
WHO/World Bank burden of disease studies (WHO, 1999a) estimate the continental
DALY to be 1.141 million for sleeping sickness, 34.506 million for malaria and 5442
for tuberculosis million. Malaria is considered a major vector-borne disease burden
with emerging problems of antimalarial drug resistance. Tuberculosis is a chronic
disease with increasing incidence, drug resistance and is associated with HIV
infection. It must be acknowledged that there is gross under-detection of sleeping
sickness because where outbreaks or epidemics occur, the disease is associated with
areas with civil unrest and poor rural populations (Mbulamberi, 1989; Okia et al.,
1994). Unlike malaria, sleeping sickness is always fatal if not treated and the costs of
treatment are high.
1.7 Focalisation of sleeping sickness
The geographic distribution of rhodesiense sleeping sickness (RSS) is limited by the
distribution of vector and reservoir hosts with the exact geographical location of the
foci occurring within these limits being currently unexplained. South-eastern Uganda
where the species of tsetse G. f fuscipes is found has long been considered the focus
of rhodesiense sleeping sickness (RSS) (Mackichan, 1944; Robertson, 1957; Morris,
1959; Ormerod, 1961; Robertson & Baker, 1958; Abaru, 1985; Mbulamberi, 1989).
Recent studies indicate that areas further north and west of the focus are now also
endemic (Enyaru et al., 1999; Fevre et al., 2001). The focality of sleeping sickness
has long been reported but other than one study carried outside the previously known
endemic focus (Fevre et al., 2001), there have been no cluster studies like those
carried out on the distribution of types of cancers (Glick, 1979; Kulldorff &
Nagarwalla, 1995; Hjalmars et al., 1996) nor have these residual foci been accurately
mapped (Scott, 1970). The possible aetiological factors explaining the occurrence of
clustering are related to human-fly contact. Peridomestic breeding sites of G. f.
fuscipes in a sleeping sickness focus in Busoga, Uganda were identified in coffee and
banana plantations, and in L. camara thickets and around houses (Okoth, 1986).
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1.8 Land cover and the risk for sleeping sickness
The last epidemic in south-eastern Uganda lasted from 1976 to the early 1990s
(Abaru, 1985; Mbulamberi, 1989; Lancien, 1991; Enyaru et al., 1992). The vector
associated with the epidemic was G. f fuscipes. The reason for the outbreak is
believed to be a result of cessation of cotton growing, which used to occur between
Lakes Victoria and Kyoga and which involved the control of the local vegetation that
excluded flies (Koerner, et al., 1995). Cotton growing was abandoned during the
1970s, and the shrubby weed L. camara and later G. f. fuscipes invaded the area. A
similar growth of L. camara was associated with an outbreak of sleeping sickness,
involving the same species, in the Alego district of Central Nyanza, Kenya in the
1960s (Willet, 1965). One theory for the occurrence of the Alego outbreak was
previous heavy rains in 1961 with a rise of the Lake Victoria level by 7ft by 1961
(Ford, 1971). G.f fuscipes is believed to have moved inland with the shoreline.
Prediction of the occurrence of sleeping sickness in time and space may be used to
assist in averting morbidity and mortality due to the disease. Analysis of sleeping
sickness patient data from south-east Uganda and mean Normalised Difference
Indices (NDVIs) suggests that satellite imagery may be used to monitor spatial
variation in disease risk and may contribute towards the production of risk maps of
vector-borne diseases so that scarce health service resources can be targeted at areas
of greatest need (Rogers & Williams, 1993). NDVI is used as a measure of plant
growth, vegetation cover and biomass production from multispectral satellite data. In
Togo, maps of high-risk areas of disease transmission have been produced
(Hendrickx et al., 1997). The incidence of sleeping sickness in Tanganyika was
found to be related to seasonal variation in temperature with a significant correlation
between the monthly mean maximum temperature and the number of patients
diagnosed during the next one or two months, high temperatures being related to
high incidence (Fairbairn, 1948). In Kenya, a rhodesian sleeping sickness outbreak in
1980 followed the highest rainfall in the months of April and May in the previous 10
years (Wellde et al., 1989).
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It has been shown that on the lake shore of Lake Victoria the density of G. f. fuscipes
was correlated with the width of the lacustrine forest (Glasgow, 1954). However,
since then, there has been severe destruction of the vegetation. The implications of
this destruction to the distribution and abundance of G. f fuscipes and therefore, to
the current risk for sleeping sickness have not been evaluated. Development of the
land may initially cause an increase in infection due to the intrusion of the tsetse
habitat by people (Apted et al., 1963; Robertson, 1963). It is clear that the size of the
fly-belt (Ford & Katondo, 1977) is diminishing under the pressure of population.
However, the rate at which this is happening and its association to changes in
sleeping sickness incidence is not clear. Changes in the distribution of Glossina
morsitans and Glossina fusca in Africa over the next 50 years have been predicted
(Reid et al., 1997a,b). Morris (1951) showed that a reduction of tsetse habitat
especially by the removal of riverine forest could bring about a sustained reduction in
the risk of human infection.
It is now generally accepted that environmental factors are important as risk factors
for the acquisition of sleeping sickness (WHO, 1998). Some environmental factors,
such as proximity to and activities near bush thickets, especially along rivers, are
considered to be of significance. However, their significance has not been quantified
and used for the development of risk maps and priority areas of control. Other factors
such as the significance of peridomestic transmission (Okoth, 1986) are still
controversial and need to be assessed relative to the distribution of sleeping sickness.
Tsetse can be present in abundance but with the absence of infected hosts,
transmission of disease may be limited. Cattle have been demonstrated to be an
important reservoir of the rhodesiense sleeping sickness and therefore may play a
major role in its spread (Onyango et al., 1965; Maudlin et al., 1990; Hide & Tait,
1991; Hide et al., 1994, Fevre et al, 2001). In 1956 and 1966 in Uganda, G. f.
fuscipes were reported in abundance along the Malaba river in the vicinity of the East
African Trypanosomiasis Research Organisation (EATRO), but there was no
evidence of infection in human beings, cattle and in the G. f. fuscipes (Roberstson,
1957; Mwambu & Odhiambo, 1967). However, at the lake shore tsetse were in
abundance, with infections in man, cattle and the tsetse. In 1980, a tsetse survey
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revealed plenty of G. f. fuscipes in the River Osia also neighbouring EATRO but
there were no sleeping sickness patient reports from this area at the time (Okiria,
1981). It is apparent that G. f. fuscipes feeding habits in south-east Uganda are due to
the availability of hosts and domestic livestock especially cattle and pigs are
becoming increasingly important in this respect (Burridge et al., 1970; Moloo, 1980;
Okuna et al., 1986; Maudlin et al., 1990; Waiswa et al., 2003) and therefore parasite
hosts targeted control is apparently very important.
1.9 Surveillance of sleeping sickness
The available methods of sleeping sickness patient detection in south-eastern Uganda
are as follows: fixed-post patient finding accounts for over 90% of the patients
detected, while less than 10% of the patients are detected through either mobile
teams or by sleeping sickness assistants (SSAs). Proximity to health units may affect
the distribution of reported patients of sleeping sickness (see Chapter 4). This effect
is also important in understanding the public health impact of the distribution of
health units for sleeping sickness for surveillance and control. In 1995, following the
observation that despite the reinforcement of several national control programmes,
sleeping sickness could not be curbed, WHO requested stronger international
coordination (WHO, 1999b). A new programme against sleeping sickness was
established with additional human and financial resources. In addition to
strengthening these tools and programmes, WHO has decided to focus efforts on the
development of an epidemiological surveillance system and an information system.
In central and west Africa, WHO has used GIS to promote the understanding of the
distribution of gambiense sleeping sickness (GSS) to enhance targeting of screening,
treatment and vector control (Cattand, 2001; Cattand et al., 2001). There have been
attempts to design frameworks for evaluation of surveillance of GSS e.g Shaw &
Cattand, 2001. It is therefore important to use empirical data to identify
epidemiological markers for sleeping sickness surveillance that can be applied to
these frameworks.
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Since rhodesiense sleeping sickness (RSS) causes obvious symptoms, under-
detection is likely to be less than in the milder form gambiense sleeping sickness
(GSS). But the symptoms of RSS are fever commonly associated with severe
headache, joint and muscle pains, complicating its differential diagnosis. Due to the
lack of pathognomic signs and the toxicity of the drugs used for treating sleeping
sickness, diagnosis of sleeping sickness is strictly based on the demonstration of the
parasite in blood, gland aspirate or cerebrospinal fluid (WHO 1998).
The countries where sleeping sickness occurs are generally very poor (Kuzoe, 1993;
World Bank, 2000) and may not be able to sustain current control strategies.
Delimitation of the optimal location of control programmes is therefore a priority if it
can reduce costs. A geographical targeted approach to control is now being
encouraged (Brooker et al., 2000a) and there have been attempts to apply similar
ideas to malaria, onchocerciasis and sleeping sickness (Rogers & Williams, 1993;
Ngoumou et al., 1994; Omumbo et al., 1998; Snow et al., 1999). The criticism of
using a cartographic approach has been that maps were difficult to update easily and
comparisons between areas shown on different maps was difficult (Yoon, 1995).
However, this has all been made easier by the application of geographical
information systems (GIS).
1.10 Utility of Geographical Information Systems (GIS) for public
health and epidemiology
A Geographical Information System (GIS) is defined as an organized collection of
computer hardware, software, geographic data and personnel designed to efficiently
capture, store, update, manipulate, analyze and display all forms of geographically
referenced information (Maguire, 1991). Every mapped feature is linked to a record
in a tabular database and may be related to records in other databases making
analysis of geographical data possible. GIS have been identified as useful tools for
operational and applied field research in epidemiological and public health aspects of
sleeping sickness (Mayer, 1983; Gesler, 1986; Twigg, 1990; Marshal, 1991; Scholten
& de Lepper, 1991; Walter, 1993; Briggs & Elliot, 1995; Loslier, 1994; Clarke et al.,
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1996; Smans & Esteve, 1996; Vine, 1998; Robinson, 1998; Rushton, 1998; Moore &
Carpenter, 1999). GIS are novel research tools that have not yet been applied to
understand the epidemiology of human African trypanosomiasis on a scale that can
be useful for sub-national control programmes. The increasing availability of GIS
presents an opportunity to introduce into epidemiological studies in Uganda,
temporal and spatial elements that are often neglected (Scholten & de Lepper, 1991;
Rogers & Williams, 1993) to understand further the epidemiology and to improve the
control of sleeping sickness. Advances in the analysis of spatial data or vector borne
diseases using GIS and global and local spatial statistics allow for a quantitative
analysis of the aggregation and degree of clustering of disease, patients, vector
distribution and their determinants (Upton & Fingleton, 1985; Gesler, 1986; Getis &
Ord, 1992; Kitron et al, 1992; Beck et al., 1994; Kitron et al., 1994; Brown et al.,
1995; Glass et al, 1995; Clarke et al., 1996; Ord & Getis, 1995; Getis & Ord, 1996;
Kitron et al., 1996).
The main objective of applying GIS and spatial data analysis in public health and
epidemiology is to enable informed decision analyses for disease intervention, but its
application in this regard is still limited (Openshaw, 1996; Burrough & McDonnell,
1998). It needs to be evaluated for use at sub-national levels because of its focality.
Examples of GIS applied to improved disease control are few but results show the
potential of the technology. GIS has been applied for decision analysis in the
interventions of animal trypanosomiasis. In eastern Zambia, GIS was used to
combine data for six environmental variables: cattle density, human population
density, land designation, relative arable potential, crop use intensity and proximity
to existing control operations (Robinson et al., 1999). The distribution of tsetse in the
area was predicted using multivariate methods (Robinson et al., 1997). Veterinarians
and biologists working in the region established criteria weights for the input
variables and the data were integrated using weighted linear combination to prioritize
areas for animal trypanosomiasis control. The results of this analysis were used to
delimit the optimal location of community-based tsetse control program in the
Eastern Province of Zambia.
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GIS was used in the implementation of the DOTS (directly observed therapy, short
course) control strategy for tuberculosis in northern KwaZulu/Natal, South Africa.
GIS distance and buffering functions were used to show and quantify how much a
community-based programme increases access to tuberculosis treatment, and
promote its further use for decision support and programme management in
developing countries (Porter, 1999; Tanser & Wilkinson, 1999).
Diurnal temperature difference images (dT) from the Advanced Very High
Resolution Radiometer (AVHRR) were created and tested for association with the
relative risk distribution of schistosomiasis (Malone et al., 1994, Abdel-Rahman et
al., 1997). AVHRR is a radiation detection imager that can be used for remotely
determining the surface of the earth temperature. An inverse relationship was found
between dT values and prevalence of Schistosoma mansoni. It was proposed that
AVHRR thermal difference maps (Hastings & Emery, 1992; Cracknell, 1997) could
be used to predict environmental risk of schistosomiasis.
Many health studies have used remotely sensed data for monitoring, surveillance, or
risk mapping, especially of vector borne diseases (Linthicum, 1987; Hugh-Jones,
1989; Beck et al., 1997; Robinson et al., 1997; Brooker et al., 2002). Most of these
studies have used data from USA Landsat, the French Systeme Pour L'Observation
de la Terre (SPOT) and the National Oceanic and Atmospheric Administration
Advanced Very High Resolution Radiometer (NOAA AVHRR) (Beck, 2000). The
World Health Organization Global Malaria Control Strategy has advocated the use of
satellite imagery by control services to provide environmental information for
malaria stratification, monitoring and early warning (Thomson et a/. 1997, 1999).
Remote sensing has been use as a landscape epidemiological tool to identify villages
at high risk for malaria transmission (Beck et al., 1994, 1997, Hacker & Legters,
1994).
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1.11 Control of sleeping sickness in eastern Uganda
Since the epidemic in the 1980s, the control of sleeping sickness eastern Uganda has
been attempted using three approaches. Firstly, there has been patient detection and
treatment at 17 fixed post sleeping sickness treatment centres. This approach was
strengthened by the use of sleeping sickness assistants who were trained to make
thick blood smears from sleeping sickness suspects and to take the smears for
examination at the nearest sleeping sickness treatment centres. Mobile teams
comprising of a clinician and microscopists were used whenever an increase in the
number of cases of the disease was noted in a particular area. The second approach
was vector control by the use of tsetse pyramidal Lancien traps impregnated with
deltamethrin at a density of 10 traps per square km (Lancien et al., 1990; Lancien,
1991). Trials of the use of insecticide treated cattle as a tsetse control method
(Thomson, 1987; Warnes et al., 1999) were carried out in small areas in Buteba,
Mukuju, Masaba and Masafu subcounties (Lancien, 1991; Okiria et al., 2002). Aerial
spraying was carried out in Busoga in the 1980s (Kangwagye, 1987). The third
approach was control of the animal reservoir by treatment of all cattle found to have
trypanosomiasis by microscopic examination using trypanocides. Most of these
activities were funded by assistance from the European Union (EU). However, when
the funding from the EU ceased, maintenance of the control campaign, particularly
the tsetse trapping, was not possible because of the costs of the operations. There is
therefore a need to identify a more cost-effective and sustainable strategy for the




The broad objective of this study was to identify and develop epidemiological
surveillance tools for T. b. rhodesiense sleeping sickness and apply them in the
determination of the burden of the disease and evaluation of case finding strategies.
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1.12.2 Specific objectives
The specific objectives of the study were to:
1. determine to the level of under-detection of T. b. rhodesiense sleeping
sickness in eastern Uganda;
2. determine the burden of T. b. rhodesiense sleeping sickness outbreaks
3. determine the spatial and temporal risk factors for early detection and
thus under-detection of T. b. rhodesiense sleeping sickness;
4. assess the health seeking behaviour among T. b. rhodesiense sleeping
sickness patients;
5. describe the spatial and temporal trends of T. b. rhodesiense sleeping
sickness at village scale;
6. explore the utility of remote sensing for identification of village scale
risk factors for T. b. rhodesiense sleeping sickness.
1.13. Ethical considerations
The anonymity of subjects was maintained throughout. All invasive procedures for
the collection and testing of specimen were carried out as part of the sleeping
sickness control programme. All persons who tested positive for sleeping sickness
during surveys were transported to the nearest sleeping sickness treatment centre and
treated. In general, no additional procedures on patients, beyond what was already
done, were required for this study.
26
Chapter 2 Quantifying the level of under-detection of
Trypanosoma brucei rhodesiense sleeping sickness cases
2.1 Summary
To quantify formally the level of under-detection of Trypanosoma brucei
rhodesiense sleeping sickness during an epidemic in Uganda, a decision tree model
was developed. The values of the model parameters are estimated from previously
published records of the duration of symptoms prior to presentation and the ratio of
early to late stage cases in 760 sleeping sickness patients presenting at LIRI hospital,
Tororo, Uganda during the 1988 to 1990 epidemic of sleeping sickness. For the
observed early to late stage ratio of 0.47, it is estimated that the level of under-
detection in the catchment area of LIRI hospital was 0.39 (95% CIs 0.37-0.41).
Based on this value, it is calculated that for every one reported death of sleeping
sickness, 12.0 (95% CIs 11.0-13.0) deaths went undetected. The measure of early to
late stage presentation provides a tractable measure that may be used across sub-
Saharan Africa to determine the level of sleeping sickness under-detection and to
gauge the effects of interventions aimed at increasing treatment coverage.
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2.2 Introduction
Sleeping sickness is likely to be highly under-reported as outbreaks tend to occur
mainly among the rural poor and during civil strife when control measures are
difficult to apply (Mbulamberi, 1989; Okia et al., 1994). In addition, the main tool
used for diagnosing sleeping sickness at the field level is microscopy, and the
sensitivity of diagnosis by this method is low (Cattand & de Raadt, 1991).
Estimating the true occurrence of sleeping sickness under such circumstances is,
therefore, difficult. To date, crude estimates based on historical records of sleeping
sickness surveillance and case finding rates have been used. WHO has reported a
steep increase in reported sleeping sickness cases despite a ten-fold reduction in the
population under surveillance from the mid 1970s to present (WHO, 2000a). Using
this information, WHO estimates that there are approximately 300,000-500,000 new
cases of sleeping sickness but only 45,000 are reported, that is, approximately 10
infected to one reported case, indicating a high level of under-detection (WHO,
1998).
Sleeping sickness progresses from hemato-lymphatic (early stage) to meningo-
encephalitic (late stage) involvement and if untreated kills the patient (WHO, 1998).
In the case management of sleeping sickness, the detection of trypanosomes in gland
or lymph node aspirates or blood is always followed by a lumbar puncture to
determine whether there is involvement of the central nervous system (CNS) (WHO,
1998). Drug treatment when the CNS is involved is different from that used when the
parasite is still restricted to the hemato-lymphatic system (WHO, 1998). No
melarsoprol treatment failures for late stage treatment have been reported for T. b.
rhodesiense sleeping sickness although approximately 26% treatment failure has
been reported in late stage T. b. gambiense sleeping sickness patients in parts of
Uganda (Legros et al., 1999a,b). Rhodesiense sleeping sickness is mainly detected
mainly by passive case finding, with patients presenting at a health facility and
diagnosis based on microscopic detection of trypanosomes (WHO, 1998). The level
of under-detection associated with such passive case finding systems is believed to
be high, but is as yet, not quantified.
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A decision tree model of sleeping sickness presentation is described to estimate the
proportion of cases that went undetected in the catchment area of LIRI hospital, a
specialist sleeping sickness hospital located in an endemic focus of the disease in
Tororo District, south east Uganda. The parameter values of the model are estimated
from empirical data on the duration of illness in sleeping sickness cases prior to
hospital presentation and the ratios of early to late stage cases. The implications of
the findings for the true burden of sleeping sickness and policy decisions aimed at
alleviating this burden are discussed.
2.3 Materials and methods
2.3.1 Hospital records and case definitions
Data previously published by Odiit and colleagues (Odiit et al., 1997a) on admission
patterns to the LIRI sleeping sickness hospital between 1988 and 1990 were utilized
to estimate rates of progression of the disease necessary for the calculation of under-
detection using the model described in this paper. LIRI sleeping sickness hospital is
situated in Tororo district, an area endemic for sleeping sickness (Enyaru et al.,
1992). The data set used in this study is the most up-to-date, extensive and
comprehensive dataset of its kind. A total of 760 patients were diagnosed with
sleeping sickness based on the WHO criteria of detection of trypanosomes in blood,
cerebral spinal fluid, gland or chancre aspirate (WHO, 1998). A sleeping sickness
case is defined as late stage if examination of cerebrospinal fluid (CSF) revealed
•2
white blood cell counts above 5 cells/mm or the presence of trypanosomes, and as
early stage if the CSF was normal. The clinical features for sleeping sickness are not
useful for distinguishing between the early and late stage, which necessitates the
invasive procedure of a lumbar puncture.
Of the 760 patients, 240 were classified as early stage, 515 as late stage and for 5, the
stage of disease was not recorded. Therefore, 755 were used in the analysis. Out of
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40 patient deaths that were not due to adverse reactions, duration of symptoms was
available for 30 of them. The duration of symptoms between onset and presentation
at hospital was recorded for 472 late stage patients including the 30 deaths with
records.
2.3.2 Model structure
A decision-tree model structure is shown in Figure 2.1, and the parameters defined in
Table 2.1. It is assumed that there is no increased mortality due to sleeping sickness
in the early stage of the disease; this is a conservative assumption, in terms of
estimating the proportion of sleeping sickness cases that die undetected. A proportion
of sleeping sickness cases will present at a health facility as early stage patients, E,
with a probability feariy The proportion of cases that do not present at early stage, E,
either present as late stage cases, L, with a probability fate, or die undetected, U, with
a probability 1 -fiate.
Therefore, the model has only three possible outcomes for each sleeping sickness
case: (1) presentation with early stage disease, E, with probability feariy, (2)
presentation with late stage disease, L, with probability (1 -feariy)fiate or (3) dying
undetected, U, with probability (1 -feariy)( 1 -fate), where E, L and U are all proportions
and sum to 1.
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Figure 2.1. Structure of the decision tree model for rhodesiense sleeping sickness.
The boxes are the different outcomes of sleeping sickness cases. The arrows show
the directions of clinical progression. Probabilities are shown in italics.
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Table 2.1. Definition of decision tree model parameters
Model state
E Proportion of sleeping sickness cases presenting as early
E Proportion of sleeping sickness cases not presenting as early
L Proportion of sleeping sickness cases presenting as late, not early
E/L Ratio of early to late cases - estimated from empirical data
Rates
U Hazard function for onset of symptoms at which late stage cases present at health
facilities - estimated by survival analysis, using a Weibull distribution with
parameters a/ and X i
u, Hazard function for onset of symptoms at which late stage cases die - estimated
by survival analysis, using an exponential distribution with parameter Xu
Probabilities
fearly Probability of presenting at early stage, calculated using EIL and fate
flate Probability of presenting at late stage, calculated by numerical simulation of
integrals of the rates at which late stage cases present at health facilities, I, and die
of sleeping sickness, u
Outputs
U Proportion of sleeping sickness cases that die undetected
D Number of undetected deaths (cases)
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2.3.3 Parameter estimation
Neither feariy nor fate can be calculated analytically from the available data. However,
fMe may be determined numerically by estimating the competing hazard functions at
which a patient not presenting at early stage will either present as late stage, /,, or
dies, u, at time t. The dynamics of moving from E to either L or U, through time t,
may be described by the following integrals:
By setting o tol, then
(Equation 2.1)
flate = \l,E, dt
1=0
and
, . ' f f j (Equation 2.2)1-/^= \uiEt d/.
(=0
The hazard functions lt and ut were estimated from survival analyses of time from
onset of symptoms to late stage presentation for 472 late stage patients and the subset
of 30 patients dying due to sleeping sickness, respectively (Figure 2.2). It is assumed
that the survival curves derived for the 30 patients that died were the same as for all
sleeping sickness cases that die. Weibull distributions of the form
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Table 2.2. Survival analysis parameter estimates of rates of occurrence of late stage
patients and undetected deaths
Rates Scale Confidence Shape
parameter Intervals parameter
(X) (CIs) (a)
Late stage presentation, lt 7.3 x 10"3 (6.7-8.0) x 10-3 1.11
Undetected death, u, 1.1 x 10"2 (0.7-1.5) x 10"2 1
h,=aXta~\ (Equation 2.3)
in which h refers to either I or u, X is the scale parameter, and a is the shape
parameter, were fitted to the survival data using MINITAB (State College, PA, USA)
statistical software (Burrows, 1999). The value of a was only relevant if it was
significantly different (p<0.05) to 1, otherwise it was set to 1 and Equation 2.3
reduced to h, = X, an exponential distribution. This was then applied to the survival
curve for the deaths. Using the hazard functions lt and u, estimated from the survival
analyses, the parameter fate was then derived by numerical iteration of the integral
equations 2.1 and 2.2, assuming a starting condition of E t=o = 1. The numerical
iteration was conducted in Microsoft Excel using a one-day time step.
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Figure 2.2. The observed (black lines and filled squares) and fitted survival curves
(broken lines) for time of presentation of sleeping sickness cases:
(a) 472 patients presenting as late stage cases and (b) 30 late stage cases dying of
sleeping sickness within one week of admission. The fitted hazard functions for late














The parameter feariy was derived by expressing the probability in terms of the ratio
EIL andfate• By definition
feariy (Equation 2.4)
\ J early JJ late




where fate is estimated using the procedure described above and the ratio EIL is
equivalent to the observed ratio of early to late stage cases recorded at LIRI hospital
(Odiit etal., 1997a).
The level of under-detection, that is the proportion of infections resulting in
undetected deaths U, was then simply calculated as
After calculating feariy, the number of deaths not reported, D, can be calculated from
the equation
where feariy is the ratio of early cases (240) to total cases (detected (755) and
undetected, D).
Mi -/M'-M (Equation 2.6)
feariy =240/(755+77) (Equation 2.7)
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2.3.4 Monte Carlo simulation
The survival analysis gives a joint maximum likelihood estimation of a and X. The
analysis assumes that the estimate of X is normally distributed with a mean and
standard deviation as estimated from the survival analysis. To obtain the 95%
confidence intervals of the model outputs, a Monte Carlo simulation was used to
calculate the distribution of I, and u, respectively (Snedecor & Cochran, 1989). These
estimates were used to determine fate. The decision tree model (Figure 2.1) was
simulated for 1000 iterations. At each iteration, values of X describing I, and u, were
chosen at random from their respective normal distributions, while a was held
constant. The model simulation was conducted in Microsoft Excel. To test for
sensitivity and robustness, the rates, I, and ut were adjusted by plus or minus 10%
variation of A, to determine the effect on the estimates of the model.
2.4 Results
2.4.1 Survival analyses
The results of the survival analyses are shown in Table 2.2, and the observed and
fitted survival functions displayed in Figure 2.2. For I,, the Weibull distribution gave
a value of a significantly different from 1 (x2= 8.7, ldf, P=0.003). For uh a was not
significantly different to 1 (%2= 1.7, ldf, P=0.187) so the Weibull collapsed to an
exponential distribution.
2.4.2 Model outputs
Using the observed early to late stage ratio of 0.47 (240/515), the results of the
Monte Carlo simulation suggest that on average, only 0.20 (95% CIs 0.19-0.20) of
all sickness cases present with early stage disease (Table 2.3) The average
probability of a sleeping sickness case dying undetected was 0.39 (95% CIs 0.37-
0.41), giving an estimated total of 478 (95% CIs 440-521) additional deaths over and
above the 40 reported non drug related deaths at LIRI hospital. If it is assumed that
all the undetected cases that failed to receive treatment died of sleeping sickness,
then for each one of the deaths recorded at LIRI hospital, there were an estimated
12.0 (95% CIs 11.0-13.0) undetected deaths in the catchement area of LIRI hospital.
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Adjusting the estimate X for lt by plus 10% resulted in a decrease of 8% to a ratio of
1:11.0 (95% CIs 10.0-11.9) of detected to undetected deaths or 437 (95% CIs 401 -
477) undetected deaths, while adjusting by minus 10% resulted in an increase of 11%
to a ratio of 1:13.3 (95% CIs 12.1-14.4) or 530 (95% CIs 485-575) undetected
deaths. Adjusting the estimate X for u, by plus 10% resulted in an increase of 11% to
a ratio of 1:13.3 (95% CIs 12.2-14.4) of reported to undetected deaths or 530 (95%
CIs 486-575) undetected deaths, while adjusting by minus 10% resulted in a decrease
of 10% to a ratio of 1:10.7 (95% CIs 9.8-11.6) or in 430 (95% CIs 393-465)
undetected deaths. Adjustments of these inputs have an approximately proportional

































This is the first attempt to estimate under-detection for sleeping sickness based on a
framework taking into account the progression of the disease and utilizing sleeping
sickness case records. Public health professionals and decision makers can use this
model to define which regions in the country need to get priority for sleeping
sickness funds. In Chapter 3, the model is applied to sleeping sickness outbreak area
to improve the calculation of the Disability Adjusted Life Years (DALYs) due to
rhodesiense sleeping sickness.
The data used in the model were obtained from an area (Odiit et al., 1997a) with a
relatively low expected probability of under-detection, having better health service
and other infrastructure compared to other sleeping sickness areas in Africa.
Although the model estimates are conservative in the sense that they assume no
increased death rate due to early stage disease, they still reveal significant under-
detection; for every three reported cases in the LIRI hospital catchment area,
approximately two additional cases went undetected and the persons died of the
disease.
The case fatality rate on admission of rhodesiense sleeping sickness to LIRI hospital
was approximately 6% with 40 reported deaths (Odiit et al. 1997a) compared to an
estimated 500 undetected deaths during 1988-90 epidemic peak, as estimated by the
model. Therefore, for every one patient dying on admission approximately 12 are
dying unseen. There are no local vital statistics to verify this. National estimates put
the crude death rate (CDR) at approximately 20 per 1000 (UN, 1997) indicating
18,000 deaths per year in the LIRI hospital catchment area of approximately 900,000
people (1991 national census projections). Therefore, the model estimates for the
area indicate that sleeping sickness contributed to just under 1% of the total deaths
but the fraction would have been higher in some age groups because adults are more
at risk for acquiring sleeping sickness than children. Statistics are not available for
comparison to other infectious diseases (e.g. malaria, tuberculosis, AIDS). However,
the opportunities of preventing the deaths of the sleeping sickness cases are greater
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than for many other diseases (e.g. AIDS) and the sleeping sickness cases may die
without being recognized by the health system. These estimates of deaths due to
sleeping sickness emphasize the magnitude of the burden of sleeping sickness
especially where it occurs in epidemics in areas with poor surveillance (WHO,
2000a). Currently, the major burden of sleeping sickness is due to mortality but if a
greater proportion of cases could be detected, almost all of the deaths would be
preventable.
In south-eastern Uganda, between 1976 and 1983, there was an epidemic of sleeping
sickness due to the breakdown of control services associated with political turmoil as
well changes in agricultural practices with resultant bush encroachment (Abaru,
1985; Matovu, 1982; Mbulamberi, 1989). A total of 19,974 sleeping sickness cases
were detected and the early to late ratio was approximately 0.5. This suggests that
approximately 13,000 people could have died undetected in south-eastern Uganda
during this time out of a population at risk estimated to be 3 million people (1991
population census) during the epidemic. Going by the national crude death rate
(CDR), there were an estimated 60,000 deaths per year in the entire south-eastern
Uganda. Therefore, the model estimated that deaths due to sleeping sickness
accounted for approximately 1% of the total deaths. This low percentage contribution
cannot be easily detected given the poor quality of vital statistics available in the area
at that time.
The conservative assumption that most sleeping sickness cases progress to the late
stage before they die from the disease is supported by empirical evidence (Odiit et
al., 1997a). It is assumed that the duration of symptoms to death for undetected cases
is the same as the reported deaths of patients who succumb to the disease while in
hospital. This is a safe assumption since patients who died as a result of drug
reactions were excluded from this group and this is the best obtainable estimate given
that it is not possible to analyze death rates of undetected cases. Sensitivity analyses
by adjusting X estimates for lt and ut by plus or minus 10% indicated that the under-
detection estimates are fairly robust to changes in these hazard rates. Although data
from 1988 to 1990 is used for designing the model, the data are still applicable to the
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present day because the sleeping sickness detection and treatment policies have not
changed since the data were collected.
There is a lack of reliable statistics and under-detection of disease in sub-Saharan
Africa because of, amongst other reasons, infra-structural and costs constraints
(Snow et al., 1999). As a result, disease estimates are often guesses based on a
clinical and not a diagnostic basis. To solve this problem, other epidemiological
methods have been used in other infectious diseases in Africa to determine the true
burden of disease. The prevalence of helminthic infections in the Republic of
Cameroon was estimated from data on infection prevalence in school children
(Brooker et al., 2000b) following an earlier study showing that infection prevalence
in school children is higher than in the entire community (Guyatt et al., 1999). In
Mali, the prevalence rate of schistosomiasis in school children was used as an index
of endemicity in the community (Traore et al., 1998). In the Republic of Cameroon,
estimates of the number of cases of schistosomiasis in the country have been made
using models (Ratard et al., 1992). A decision tree approach for estimation of rabies
under-detection in Tanzania has also been reported recently (Cleaveland et al.,
2002). However, there have been no equivalent studies for sleeping sickness. The
results of such studies improve the accuracy of estimates of disease burden that are
measured using disability-adjusted life years (DALYs) (Murray, 1994) which need
estimates of true mortality in their calculation (See chapter 3).
This study emphasizes the need to improve surveillance of sleeping sickness.
Strategies that improve both passive and active case findings should be addressed.
These will include increased awareness among the affected communities and their
health workers as well as commitment of more resources for health services at the
local level. Given the high mortality of this zoonotic disease, preventive measures
such as chemotherapy of the livestock reservoir for trypanosomiasis can greatly
reduce the risk of outbreaks occurring in rhodesiense sleeping sickness endemic
areas like eastern Uganda with predominantly agro-pastoral agricultural systems
(Fevre et al., 2001; Welburn et al., 2001; Wendo, 2002). The model designed in this
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study provides a means of assessing the cost-effectiveness of these interventions by
quantifying the potential deaths that can be averted.
The use of the early to late ratio is a simple disease measure that is readily available
in all sleeping sickness areas because of the necessity to stage sleeping sickness
patients by lumbar puncture and CSF examination to determine how they will be
treated. Thus, the method presented could be applied more widely to better estimate
the actual burden of sleeping sickness in rural Africa. This has important
implications for health policy in as far as allocation of resources is concerned. The
burden of sleeping sickness is currently grossly under-estimated and may contribute
to relative under-funding for surveillance and awareness campaigns that are crucial
in reducing deaths for this treatable disease.
The model was designed specifically for a T. b. rhodesiense endemic area where the
disease is more rapidly progressive to death than in T. b. gambiense. However, the
early to late ratio of sleeping sickness cases may also be used to give an indication of
the level of under-detection and death in a T. b. gambiense area. Although accurate
data on the clinical progression of sleeping sickness is available for rhodesiense
(Odiit et al., 1997a), it is difficult to obtain similar data for gambiense perhaps
because of the variability in the length of clinical stages and the generally very long
period of illness (Apted, 1970). However, specific studies of clinical progression
could be carried out to obtain estimates of the average durations of the stages to
allow application of a similar model to gambiense sleeping sickness.
In conclusion, this measure of early to late stage presentation provides a practical
method that may be used across sub-Saharan Africa to estimate the level of under-
detection of sleeping sickness and the consequent burden of disease as well as to
gauge the effects of interventions aimed at increasing sleeping sickness diagnosis and
treatment coverage. Improved case finding strategies will most certainly greatly
reduce death due to sleeping sickness. Estimates of burden of disease of specific
outbreaks can be estimated applying this methodology.
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Chapter 3 Estimating the burden of rhodesiense sleeping
sickness during an outbreak in Serere, Uganda
3.1 Summary
The burden of sleeping sickness was estimated for an outbreak of sleeping sickness in
Serere, Uganda. This study identified the unique characteristics affecting the burden of
rhodesiense sleeping sickness such as age, severity of illness, level of under-detection and
duration ofhospitalisation and uses estimates of these to calculate the burden of the disease
on the population and the health services. In addition, the study compares the relative
contribution of mortality and morbidity to the DALY estimate given the high level of
under-detection of this disease. Taking into account under-detection of rhodesiense
sleeping sickness increases the Disability Adjusted Life Years (DALY) estimate by 14
times and age weighting increases the DALY estimate by 5%. The age productive function
curve from Murray (1994) had a close fit to the sleeping sickness case distribution.
Sleeping sickness cases occupied more patient admission time during 1999 than all other
infectious diseases diagnosed other than malaria in Serere health centre. The DALY
estimate for sleeping sickness in Serere shows that the burden is much greater than might
be expected from its relative reported incidence. The estimated burden of disease provides
a better indication of the importance of sleeping sickness and should influence local




The health burden ranking for Africa for sleeping sickness is high at 2.05 million
DALYs (disability adjusted life years) compared to malaria (36.8 million),
tuberculosis (8.7 million), meningitis (3.6 million), schistosomiasis, (1.6 million) and
polio (0.8 million) (WHO, 2000b).
The DALY is a commonly used index for expressing the burden of disease, and is a
generic health measure incorporating both mortality and morbidity. It is used to gauge
the public health importance of different diseases (Murray, 1994; Murray & Lopez,
1996). The DALY was developed to enable health policy and research to prioritise
disease and for assessment of cost-effectiveness. Currently, it is mainly applied by the
World Bank and the WHO for global burden of disease estimations (World Bank, 2000;
WHO, 2000b).
In Uganda, there have been a series of epidemics of sleeping sickness reported from
the beginning of the 20th century (Christy 1903a,b; Mackichan, 1944; Abaru, 1985;
Mbulamberi, 1989). Given that sleeping sickness tends to occur where there is a
breakdown in control and affects mainly poor people, it is likely to be under detected
compared to other diseases (Mbulamberi, 1989; Okia et al., 1994). Sleeping sickness
is always fatal if not treated and the costs of treatment, usually requiring
hospitalisation, are high. Because of this, it is particularly important to assess the cost
burden to the health services in addition to the aggregate burden to individual
patients. If uncontrolled, the tendency of sleeping sickness to become epidemic
means that the DALYs averted per infection prevented or cured are high. Estimates
of the cost-effectiveness of alternative treatments of gambiense sleeping sickness
have been made and melarsoprol treatment was associated with an incremental cost
per life and DALY saved of US $ 209 and US $ 8, respectively (Politi et al., 1995)
Rhodesiense sleeping sickness is a more acute disease than the gambiense form and
available evidence supports the hypothesis that cattle are an important reservoir of T.
b rhodesiense (Onyango et al., 1965; Hide et al., 1996; Fevre et al., 2001). It appears
that current estimates of sleeping sickness burden are based on parameters of the more
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common gambiense type (WHO, 2000b) because rhodesiense sleeping sickness is not
as common or widely distributed. However, in its major focus of eastern Uganda, it
has been responsible for many deaths throughout the 20th century. Because of its
local importance, focal pattern of occurrence, rapid progression and zoonotic nature
compared to gambiense sleeping sickness, it is important to specifically estimate the
burden of rhodesiense sleeping sickness on communities in eastern Africa. For
example, trypanosomiasis control in this area will have public health as well as
veterinary benefits.
This Chapter examines how the unique features of rhodesiense sleeping sickness
influence its burden on the local population and health services in Serere health sub-
district (health services implementation level) in Soroti district (Figure 3.1) in eastern
Uganda. Decision makers at sub-national or district levels, responsible for planning
local disease control programmes, can apply these methods for priority setting.
Figure 3.1. Map of Uganda showing the endemic districts for rhodesiense sleeping
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3.3 Materials and Methods
3.3.1 Health burden indices
Two health burden indices are estimated for a rhodesiense sleeping sickness outbreak
in Serere health sub-district, Uganda. The first index is the DALY (Murray, 1994).
The second is to estimate the costs to the Serere health sub-district based on the total
costs of hospitalization and treatment. Both measures of burden were estimated for
the calendar year 1999 from patient records of the Serere health centre.
3.3.2 Disability Adjusted Life Years
DALY calculations followed the methods used in the first Global Burden of Disease
study (Murray & Lopez, 1996), and subsequent World Health Report estimates (WHO,
2000b). The calculations employed a discount rate of 3% and were conducted with and
without age-weighting.
The features of rhodesiense sleeping sickness that need to be considered in DALY
estimation are its severity of illness, case fatality rate, duration of disability, and age-
specific production losses. The information required to calculate the DALY for
rhodesiense sleeping sickness are summarized in Table 3.1.
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Table 3.1. Information required for the estimation of disability-adjusted life years
(DALYs) for rhodesiense sleeping sickness (SS).
Information type Specific data
required
Data sources
Years-of-life-lost 1) Number of deaths - health unit records of case fatality
(YLL) - case under-detection estimates
2) Life expectancy - life tables
3) Distribution of age - health unit records of case age (with or
at death without age-weighted case fatality rate and
under-detection rate)
Years-of-life-lived 1) Number of cases - health unit records of cases
with disability - case under-detection estimates
(YLD) 2) Disability - estimated from examining rhodesiense SS
weighting patients (Murray, 1994)
3) Duration of illness - health unit records of cases
4) Age-weighting of - health unit records of ages of cases
productivity
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3.3.3 Years of life lost
The number of sleeping sickness deaths in Serere health sub-district, Uganda was
estimated as a function of the number of detected deaths and the estimates of case under-
detection (see Chapter 2). Two under-detection values, 0% and 48% were applied. Forty
eight percent (95% CI, 46%-48%) under-detection was obtained for estimates made
using a model for under-detection described in Chapter Two with 4 early and 56 late-
stage detected cases entered into the model. This means that for every three cases
presenting at the health facility, approximately four went undetected and died. All
undetected cases are assumed to remain undetected, receiving no treatment and resulting
in death.
The life expectancy at the age of death was based on a hypothetical population derived
from an African standard life table with a life expectancy at birth of 50 years (UN,
1982), which was representative of the population in the Serere health sub-district. The
distribution of age of death was estimated from the distribution of ages of all cases of
sleeping sickness admitted to Serere health centre. The assumption was that the case
fatality rate is constant across age.
3.3.4 Years of life lived with disability
T. b. rhodesiense is a more severe disease (WHO, 1998). A disability weighting of 0.81
was used as estimated from the disability weighting definitions given by Murray (1994)
(Table 3.2). This disability weighting was assumed to be constant across ages and stages
of illness. Patients with rhodesiense sleeping sickness are unable to go to work or school.
Duration of illness was the mean duration of hospital stay obtained from the sleeping
sickness case records at Serere health centre for 1999. The estimate for duration of
illness did not account for post-treatment disability; although, physical and mental
retardation in children caused by sleeping sickness has been reported (WHO, 1997). The
estimates presented are thus conservative with respect to long-term disability.
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Table 3.2. Definitions of disability weighting (Murray, 1994)
Class Description Weight
1 Limited ability to perform at least one activity in one of the 0.096
following areas recreation, education, procreation or occupation
2. Limited ability to perform most activities in one of the following 0.220
areas: recreation, education, procreation or occupation
3 Limited ability to perform activities in two or more of the following 0.400
recreation, education, procreation or occupation
4 Limited ability to perform most activities in all the following areas: 0.600
meal preparation, shopping or housework.
5. Needs assistance with instrumental activities ofdaily living such as 0.810
meal preparation, shopping or housework.
6. Needs assistance with activities ofdaily living such as eating, personal 0.920
hygiene or toilet use
3.3.4.1 Age distribution ofsleeping sickness cases and other common infections at
Serere Hospital
In view of the age weighting factor in DALY estimates, the relative impact of
sleeping sickness, malaria and tuberculosis in different age groups were compared.
This was done by calculating the age distribution of sleeping sickness, malaria and
tuberculosis cases recorded at the Serere health centre and comparing it to the age-
productivity function curve of Murray (1994). The age-productivity function curve
distributes the contributions of different ages to society with the children and the
elderly regarded as being less productive.
3.3.5 Costs to the local health system
The costs to the health system per sleeping sickness patient were estimated as the
product ofmean hospital stay in days times a standard daily cost. Mean hospital stay was
calculated as the total hospital stay due to sleeping sickness divided by the number of
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sleeping sickness cases, diagnosed parasitologically, at the Serere health centre during'
1999. A standard cost per hospital day in 1999 was estimated in consultation with staff at
the Serere health centre. The staff considered that the daily hospital costs similar for all
diseases for which patients were admitted to their health centre is estimated it at US$ 2
per patient based on expenses on staff and maintenance of buildings and utilities. The
drug costs for sleeping sickness are estimated to be US$ 35 and US$ 63 for early and late
stage patients respectively (WHO, 1998). However, the costs of sleeping sickness drugs
are currently met by the World Health Organization.
The relative hospital costs of sleeping sickness to all other diseases for which
patients were admitted at the Serere health centre were compared. For each disease,
total hospital stay in 1999 was calculated and multiplied by the standard cost per
hospital day as described above. Tuberculosis was excluded from this analysis
because of the current strategy of direct observed therapy (DOT) in lieu of hospital
admission. HIV/AIDS was also excluded because of its association with concurrent
opportunistic infections and no HIV testing was carried out to objectively diagnose
the condition.
3.4 Results
3.4.1 Disability Adjusted Life Year (DALY) estimates for rhodesiense sleeping
sickness
The age-specific number of detected cases, detected deaths, estimated undetected
cases/deaths (assuming 0 or 48% under-detection), and non-age-weighted discounted
YLL (DYLL) are listed in Table 3.3. If all cases were detected (0% under-detection)
then the non-age weighted total YLL would be only 54. Of greater importance was
under-detection. Only three deaths were recorded at the health centre while it is
estimated that 80 deaths due to sleeping sickness went undetected (see Chapter 2). The
age-specific, non-age-weighted, total YLLs for 48% under-detection are also listed,
summing to a total of 1336. If age-weighting is applied, the total YLL estimate increases
to 1550.
The years of life lived with disability (YLD), for cases that recovered due to treatment
are listed in Table 3.4. The non-weighted total YLD is 64. If age-weighting is applied the
total YLD estimate increases to 72.
The total estimated DALY for rhodesiense sleeping sickness, based on 48% under-
detection and non-age-weighting, for 1999 in Serere was 1459 compared to 118 based
on 0% under-detection (Table 3.5). The majority (92%) of this DALY burden was due to
mortality in undetected cases.
3.4.1.1 Comparison to age distribution ofother diseases
The age distribution of sleeping sickness, malaria and tuberculosis cases at the Serere
health centre differed. Figure 3.2 shows the age distribution for 763 malaria cases
admitted to the Serere health centre in 1999, 104 tuberculosis cases treated in 1999
and 115 sleeping sickness cases admitted to the Serere health centre between January
1999 and August 2000. The age distribution of sleeping sickness cases has a peak in
the 20-29 age category. Rhodesiense sleeping sickness thus affects the most
productive age groups as illustrated by the close association between its age
distribution and the age-productivity function curve of Murray (1994) (see Figure
3.1). For malaria, the age distribution is skewed with the majority of cases being less
than 5 years of age. Tuberculosis age distribution is also skewed with the majority of
cases occurring among adults.
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Figure 3.2. Age distribution of malaria, sleeping sickness and tuberculosis patients
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Age-productivity function curve (Murray, 1994).
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Table 3.5. The DALY burden due to sleeping sickness at Serere health facility,






YLLs 54 (52) 1336 (1550)
YLDs 64 (72) 123 (139)
DALYs 118 (124) 1459 (1689)
The YLLs, YLDs and DALYs figures in parenthesises where calculated with age
weighting, while those outside the parentheses were calculated without age-
weighting. Taking into account under-detection of rhodesiense sleeping sickness increases
the Disability Adjusted Life Years (DALY) estimate by 14 times and age weighting
increases the DALY estimate by 5 %.
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3.4.2 Costs to the local health system of rhodesiense sleeping sickness
The 60 sleeping sickness patients at Serere health centre in 1999 stayed in hospital for a
total of 2156 days. Thus, the mean hospital stay per patient was 36 days. The standard
daily health cost estimated by health staff at the Serere health centre was Uganda
shillings 3,500 (approximately US$ 2) per day. Therefore, the total cost to the Serere
health system in 1999 was 7,546,000 Uganda shillings (approximately US$ 4,300).
However, if the drug costs (not met by the district and national health services but
donated by WHO) are included then for the total cost for 56 late stage cases was
approximately, US$ 3528 and that of the 4 early stage cases, US$ 140, giving a total of
US$ 3668 (6,235,600 Uganda shillings). Therefore, the costs of treating the 60 patients
was 13,781,600 Uganda shillings or US$ 7,700 equivalent to US$ 128 per patient.
The proportion of hospital days by disease provides a reasonable estimate of the
relative costs to the Serere health system of different diseases, as the daily hospital
costs are relatively constant across diseases. The proportions of hospital days for the
6 most common causes of admission are shown in Figure 3.3. Malaria accounted for
approximately 40% of hospital days and sleeping sickness, 30%.
Figure 3.3. Percent of hospital days by condition at Serere health centre in 1999.











Many countries in sub-Saharan Africa (SSA) are devolving implementation of health
service delivery to the local level (Jeppsson, 2001). Local burden of disease estimates
can play an important role in health sub-districts allowing a rational allocation of
resources to the highest priority diseases. The DALY is currently the most widely
accepted measure for estimating the burden of human disease (World Bank, 2000). In
this Chapter, it has been shown that with relatively small amounts of available data from
a local in-patient health centre, useful estimates for the components of the DALY can be
made. For example, the estimates for case-fatality rate and age-specific case distribution
based on the 60 sleeping sickness patients at the Serere health Centre in 1999 are
virtually identical to estimates made in previous larger studies at the LIRI sleeping
sickness hospital in eastern Uganda (Odiit et al., 1997a,b). Thus, DALY estimates for
local planning purposes can be readily estimated from local health centre data using the
data outlined in Table 3.2.
WHO estimates the treatment costs (hospitalisation and drugs) per patient of sleeping
sickness to be in the order of greater than US$ 120 (WHO, 1998). The WHO estimate is
similar to the present estimate ofUS$ 128. In addition to DALY estimates, hospital costs
are also an important planning tool for local health decision makers. These data can be
simply derived from in-patient records. As a starting point, it is assumed that
hospitalisation costs are relatively standard across diseases. However, this is not
completely true. Drugs for the treatment of sleeping sickness are administered parentally
and are costly. Due to toxicity of the drugs used, complications are frequent and increase
the costs of treatment. Clearly, costs to individual patients beyond those to the local
health system are also important. Future investigations will include these costs.
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This is the first study to estimate the DALY for rhodesiense as opposed to gambiense
sleeping sickness. Given that sleeping sickness of both types is invariably fatal if not
treated and that sleeping sickness surveillance is relatively weak (WHO, 1998), it is not
surprising that mortality, particularly mortality due to undetected cases, dominates the
DALY estimate. Given that 95% of treatments for rhodesiense sleeping sickness were
successful at Serere health centre, there appear to be great potential benefits in enhancing
strategies for identifying undetected sleeping sickness cases. Such strategies are
investigated in Chapters 4, 5 and 7.
Although this study does in general represent the true situation, it has a few limitations.
The study did not take into account any post-treatment disability due to sleeping
sickness. This is difficult to quantify because there are no systematic follow-ups of
sleeping sickness cases post-treatment. A study in Cameroon (WHO, 1997) showed that
children with a past history of sleeping sickness had significantly lower weight, height
and mid-arm circumference and spent more years in school. Comparison with
HIV/AIDS for causes of bed occupancy could not be objectively assessed because HIV
testing was not carried out. A study conducted in an urban hospital medical ward in
Uganda identified HIV/AIDS as a major contributor to bed occupancy (Tembo et al.,
1994).
Despite its accepted use (World Bank, 2000; WHO 2000b), there are some criticisms
of the DALY methodology. Paalman (1998) are concerned about the variations in the
strengths and weakness of databases and value judgements of disability weightings.
Musgrove (2000) highlights age weighting as a controversial parameter of the DALY
given the argument of preference for saving young adult lives over those of young
children or elderly people. Nonetheless, in the absence of better alternatives, the
DALY still remains the most objective way for allocation of resources.
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Recent economic impact assessments of animal and human trypanosomiasis have not
given adequate coverage to the public health burden of the disease (Budd, 1999;
Kristjanson et al., 1999; Swallow, 2000). The T. b. rhodesiense sleeping sickness DALY
estimates in eastern Uganda indicate that where T. b. rhodesiense sleeping sickness
outbreaks occur, it has an important impact on human health. This public health impact
needs to be considered in overall tsetse and trypanosomiasis control planning.
Trypanosomiasis in cattle is an important veterinary problem in much of Uganda and
East Africa. Both tsetse control and treatment of cattle fall under the mandate of the
Ministries of Agriculture ofmost governments in Africa. The treatment of livestock for
trypanosomiasis is one of the important control strategies where T. b. rhodesiense
sleeping sickness occurs because cattle are the main reservoir of human-infective
trypanosomes (Onyango et al. 1965; Hide et al., 1996; Fevre et al., 2001). The results of
burden of rhodesiense sleeping sickness should be transmitted to the agricultural sector
departments responsible for control of tsetse and animal trypanosomiasis. This should
increase the priority ranking of tyrpanosomiasis control in the agricultural sector.
Therefore, the economic benefits of coordinated control of animal and human
trypanosomiases in rhodesiense sleeping sickness areas can be immense because of the
double benefits to both agriculture and public health.
In conclusion, the burden of rhodesiense sleeping sickness on the population and the
health services in Serere, Uganda during an outbreak, has highlighted that mortality
due to undetected cases was the major contributor to its burden on the local
population and although sleeping sickness cases may be fewer than of other
conditions, they consume an important proportion of in-patient time in the health
unit. Therefore, an outbreak of rhodesiense sleeping sickness is very costly to the
health services. Because sleeping sickness has a focal distribution in time and space,
local estimates can be important in helping local health providers allocate their
scarce health care and public health surveillance resources, to cater for the increased
requirements by the health units within a sleeping sickness outbreak area. The data
required to make these estimates can be obtained relatively easily from local hospital
records. This burden of sleeping sickness can be reduced greatly by improving the
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surveillance and control of the disease and therefore, reducing the level of under-
detection.
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Chapter 4 Spatial and temporal risk factors for the early
detection of T. b. rhodesiense sleeping sickness patients in
Tororo and Busia districts
4.1 Summary
To apply Geographical Information Systems (GIS) to study the effects of distance to
health facility on early detection of T .b. rhodesiense sleeping sickness, records of
sleeping sickness patients from 1987 to 2001 from Tororo and Busia district were
reviewed for their village of origin and clinical stage (early or late). All villages that
reported sleeping sickness and fixed post-diagnostic sleeping sickness health units in
Tororo and Busia districts, Uganda were geo-referenced. Early and late stage patient
detection patterns by health units were spatially analysed using a geographical
information system. Contour maps of distance of sleeping sickness patients to health
units were generated and the relationship between early sleeping sickness patient
detection and distance from the sleeping sickness hospital was quantified using odds
ratios (OR). Out of 1316 sleeping sickness patients admitted at LIRI and Busolwe
hospitals and Lumino health centre from Tororo and Busia districts, 471 (35.8%)
were early, 825 (62.7%) were late while 20 (1.5%) were not staged. 585 (44.5%)
came from within a 10km radius of the reporting health units. Using univariate
analysis, the proportion of early stage patients detected was found to be significantly
associated with patients originating from within 10km radius of the health unit
(RO.OOOl), to adults (>19 years) (PO.OOOl), active sleeping sickness patient
detection (P<0.05) and with annual parish incidence (P<0.0001). The significant
association of early sleeping sickness patient detection to proximity to health unit
was maintained after adjustment for confounding variables (P0.001). Applications
of GIS and the early to late stage sleeping sickness cases ratio are an informative and
powerful means of determining efficiency of surveillance of sleeping sickness. The




Sleeping sickness is an important public health problem in eastern Uganda causing
epidemics (Abaru, 1985; Mbulamberi, 1989) and has spread further in the northern
direction (Fevre et al., 2001). There have been several control programmes in the
area but still the disease persists. These programmes have been based on case
findings and treatment; tsetse control using impregnated traps and sometimes live-
bait technology (Lancien, 1991). Cattle have been shown to be a reservoir of sleeping
sickness (Onyango et al., 1965; Hide et al., 1994) and restocking of cattle sourced
from the endemic area into the northern part of this rhodesiense focus has been
reported as a major cause of the further spread of the disease (Fevre et al., 2001).
Mass treatment of cattle has thus begun as another control option.
Sleeping sickness surveillance has been identified as an essential step towards the
elimination of sleeping sickness (Cattand et al., 2002; WHO, 2002). Epidemiological
surveillance (Thacker et al., 1988) of disease can only be regarded as complete with
the timely delivery of information collected to implementers of control activities
(Orenstein & Bernier, 1990). Early patient detection ofmost diseases is important for
both control of the disease and prognosis of the individual patient. In Uganda, as
with many sleeping sickness endemic countries, surveillance of sleeping sickness is
unacceptably poor. Approximately more than half the sleeping sickness patients are
detected when they are in the late stage. Many sleeping sickness patients go
undetected and die of this fatal illness if untreated (see chapter 2). The prognosis of
sleeping sickness in the late stage is significantly poorer than in the early stage of the
disease (Odiit et al., 1997a), and the drugs used in the treatment of late stage sleeping
sickness are very toxic when compared to those used in the treatment of the early
stage (WHO, 1998).
The causes of weak surveillance and thus a greater proportion of late stage sleeping
sickness patients may be either patient factors or the health system, and include
poverty of the sleeping sickness endemic countries, poverty of the sleeping sickness
patients and the low sensitivity of the sleeping sickness diagnostic techniques (World
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Bank, 2000; Okia et al., 1994, Cattand & De Raadt, 1991). In Eastern Uganda, there
are only 17 functional designated sleeping sickness treatment centres in a sleeping
sickness endemic area of approximately 45,000 sq.km. Therefore, there is
approximately only one such centre per 2500 square km. These centres also serve as
the diagnostic centres for sleeping sickness. The distribution of health units is a
major factor in the efficient provision of health services (Perry & Gessler, 2000). In
the case of sleeping sickness, that requires diagnosis by microscope, the distribution
of such health units is very important in the surveillance of the disease. However, the
selection of health units is often static and spatial data on surveillance efficiency has
not been used to assess the pattern of surveillance structure distribution. Studies on
the effects of distance on accessibility to health care and the optimization of
distances for different levels of health care have been carried out (Morrill &
Earickson, 1968; Morrill et al., 1970; Shannon et al., 1969). Patients are more likely
to seek health care at the nearest health care unit (Shannon et al., 1969; Rahaman et
al., 1982; Stock, 1983; Kloos, 1990; Muller et al., 1998). In developing countries,
where health infrastructure is limited, it is assumed that patients will generally use
the nearest facility since most of them travel on foot (Stock, 1983). This may have
important implications for sleeping sickness where designated diagnosis and
treatment facilities are sparsely distributed.
Socio-economic factors may also have an effect on the use of health services.
Various studies have identified factors such as religion, income, availability of
transport, quality of health care, perceived level of sickness and occupation
(Engunjobi, 1983; Habib & Vaughan, 1986; Van der Stuyft et al., 1996). Although
these factors are important, they will vary widely from patient to patient and are not
measured on routine visits. Therefore, planners may not easily access them.
However, equitable geographical distribution of health facilities is often the criterion
for planning most health services.
While some studies have been carried out to determine the risk factors for the
acquisition of sleeping sickness (Okia et al., 1994; Laveissiere et al., 1994),
equivalent studies spatially analysing the distribution of early stage patients as a
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measure of the efficiency of surveillance are lacking. The ever increasing
availability, power and "user friendliness" of Geographical Information Systems
(GIS) software makes its application more simple in public health for such spatial
analyses. The application of GIS to strengthen epidemiological surveillance for
sleeping sickness has been advocated by the World Health Organization (WHO,
1999b; Cattand et al., 2001). This study applies GIS to study the effects of spatial




A "case" was defined as a sleeping sickness patient that presented in the early stage
while a "control" was defined as a sleeping sickness patient that presented in the late
stage. All sleeping sickness patients are staged on admission by examining the CSF
after a lumbar puncture for the purposes of determining which drugs are to be used
for treatment of the disease (WHO 1998). The late stage is defined as when
alterations in CSF are observed with increases in white blood cell counts to more
than 5 per cumm or with the finding of trypanosomes in the CSF, otherwise, the
patient is considered to be in the early stage.
4.3.2 Study area
Tororo and Busia districts are located in eastern Uganda at the border with Kenya
and cover an area of approximately 3500 square km (Figure 4.1, Figure 1.3). The
population was 628,000 people according to the 1991 census population (MOF,
1992) projections for 1998 with 95% of the population in the rural area. The
population is composed mainly of subsistence farmers some of whom keep livestock.
The river Malaba separates the two districts and there are several streams running
from Mount Elgon in the east into Lakes Kyoga and Lake Victoria. The sleeping
sickness patients were diagnosed from LIRI and Busolwe hospitals and Lumino
Health Centre.
4.3.3 Patient records
Records of all sleeping sickness patents attending LIRI hospital from 1987 to 2001
from Tororo and Busia districts were reviewed. Spatial, demographic and temporal
factors of sleeping sickness patients who had presented in the late stage were
compared with those that had presented in the early stage. Patient records included
the name of the patient, date of admission, age, sex, health unit, geographical origin
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to the village level, ethnic group, stage and mode of patient detection
(active/passive).
4.3.4 Geographical information systems
The positions of all villages that had reported sleeping sickness and LIRI and
Busolwe hospitals as well as Lumino Health Centre were geo-referenced using a
Geographical Positioning System (GPS) manufactured by Garmin model No 12. The
datum was set at WGS 84. The GIS software ArcView version 3.1 (ESRI, 1998) was
used to display the position of the villages and health units and to generate 10 km
radius contours around the health units (Figure 4.1).
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Figure 4.1. SS Health unit catchments
10 and 20 km radii catchment of health units and villages of
sleeping sickness cases from Tororo and Busia districts
40 Kilometers
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4.3.5 Data processing and statistical methods
The coordinates obtained were entered into a Dbase file format and imported into
ArcView GIS version 3.1. Using distance function applications of ArcView GIS, the
distances of villages from where the patients came were stratified at 10 km strata
from health units (Figure 4.1). Queries on village positions were resolved by repeat
visits to the villages. Age was categorised into 0-19 (children and adolescents) and
20 plus (adults) years. Date of admission was categorised into wet (March to May
and September to October) and dry season (December to February and June to
August) since activity patterns related to subsistence farming may affect time of
presentation to health units. Other than using the annual incidence for the entire
study area as a variable, annual parish incidences were calculated because it was
argued that awareness might be a result of high disease incidence within the closest
vicinity. A parish is the next administrative level to the village. Initial data analysis
was done through tabulating each risk or protective factor by case or control status.
Estimates of the effect of each risk or protective factor were made using logistic
regression models with case/control status (early/late stage) as the outcome. For each
factor, which had a statistically significant association with late stage presentation of
sleeping sickness (likelihood ratio x test statistic P-value <0.05), confounding by
other factors was assessed. Potential confounders were defined as variables that had a
'significant' association with risk of late stage presentation, where 'significant' was
defined as an effect with likelihood ratio x2 test statistic P-value <0.20 (Maldonado
& Greenland, 1993a,b). Interaction was assessed between each risk or protective




Between 1987 and December 2001, there were 1316 sleeping sickness patients from
Tororo and Busia districts admitted and treated at LIRI and Busolwe hospitals and
Lumino Health Centre from Tororo and Busia districts. Out of the 1316 sleeping
sickness patients, 471 (35.8%) were early, 825 (62.7%) were late, while 20 (1.5%)
were not staged. 585 (44.5%) came from within a 10 km radius of the health unit.
The annual parish incidence was less or equal to 8 for 543 sleeping sickness cases
and greater than 8 for 753 sleeping sickness cases. 1296 cases were used in the
analysis because 20 did not have records of staging of illness. The descriptive
statistics of these 1296 patients is summarised in Table 4.1. 354 (27.4%) of the
patients were children or adolescents of less than 20 years. 1207 (93%) of the
patients were detected passively i.e. came to the hospital on their own. 578 patients
(44.6%) were from the Adhola tribe while the rest were mainly from the Teso (278
(21.5%)), Samia (252 (19.4%)) and Nyole (173 (13.3%)) tribes. The male to female
ratio was 3:2 (775:521). The patients were predominantly (>98%) Christians. 667
(51.5%) of the patients reported during the wet season while the other 48.5% (629)
reported in the dry season. During the years 1987 to 1988 and 1994 to 2001 only
LIRI hospital was functioning as a diagnostic centre in the Tororo and Busia
districts.
4.4.2 Univariate analysis
There was a significant linear correlation (P< 0.001) between increasing distance
from the reporting health unit and being detected as a late stage patient (Figure 4.2).
Similarly, reported sleeping sickness incidence rates were higher nearer LIRI
hospital (where >80% of the cases were reported) than further away (Figure 4.3). The
trend of association between increasing distance from the reporting health unit and
being detected as a late stage patient remains when the data was disaggregated into
years when LIRI only was the functional sleeping sickness treatment centre, and
other years when other health units were diagnosing and treating sleeping sickness.
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Children and adolescents were significantly (P<0.001) more likely to be detected in
the late stage. In addition, early stage patient detection was more significantly
(P<0.001) likely during years of high incidence in a given parish (Table 4.1 and
Figure 4.3). Gender, season and ethnic groups were not significantly (p>0.05)
associated with early stage presentation.
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Table 4.1. Results of univariate analysis, showing the crude odds ratios (OR) and
their 95% confidence intervals (CI) for 1296 patients
Number of:
Variable Early cases Late cases cOR CI for cOR P
Age in years*
<19 96 258 0.56 (0.43-0.73) <0.001
>20 375 565
Season
Dry 221 408 0.90 (0.72-1.13) 0.41
Wet 250 417
Distance from reporting
SS health unit in km







<8 159 384 0.59 (0.46-0.74) <0.001
>8 312 441
Mode of patient detection
Active 23 66 0.59 (0.36-0.96) 0.04
Passive 448 759
Gender
Female 187 334 0.96 (0.77-1.22) 0.83
Male 284 491
Ethnic group






LIRI 379 724 0.57 (0.42-0.78) <0.001
Other 92 101
Religion
Christian 464 812 1.06 (0.42-2.68) 0.09
Moslem 7 13
Two patients had no age records
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Figure 4.3. Sleeping sickness incidence rate per 10,000 people by distance from
LIRI hospital
0-10km >10-20km >20-30km >30-40km
Distance from LIRI hospital
>40km
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Figure 4.4. Distribution of 1296 sleeping sickness cases by stage and by distance to
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Figure 4.5. Distribution of 1296 sleeping sickness cases by stage and by distance to
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Table 4.2 summarises the results of the logistic regression. Four factors remained
significantly associated with late stage presentation after controlling for other factors:
distance from the reporting diagnostic centre, age of patients, annual parish sleeping
sickness incidence and health unit. There were no significant interactions.
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Geographical Information Systems (GIS) have been used as a tool for evaluating
sleeping sickness surveillance efficiency, that is, to map and analyze the sleeping
sickness early to late stage patient ratio patterns of villages around three sleeping
sickness fixed-post health units in Tororo and Busia districts. This is a novel
approach to assessing sleeping sickness surveillance. In Chapter 2, it has been shown
that that the level of under-detection can be quantified using the early to late ratio of
sleeping sickness patients. The study has shown that there is a significant relationship
between the distance to the reporting health units and being detected in the early
stage. Similarly, the reported incidence rate for sleeping sickness was highest nearer
LIRI hospital from where over 80% of the patients were reported, suggesting lower
case detection rates further away. Distance to fixed-post health facilities therefore
appears to be a very important spatial risk factor of late stage patient detection in T.
b. rhodesiense sleeping sickness areas and thus under-detection. Regular
optimization of the distribution of fixed-post sleeping sickness diagnostic facilities
may greatly reduce late stage presentation and deaths associated with this disease.
Health workers and the affected communities need to be updated on the distribution
of the disease especially during years of low incidence and to be alerted of the
delayed detection of sleeping sickness in children. Improvement of the capacity of
diagnosis of health units in the district may ensure detection of sleeping sickness
patients in the early stage and reduce mortality associated with this disease. Setting
up new health units would be costly; however, there are already established
government and private laboratories with microscopes in the affected areas.
Currently, only a few of these health units diagnose and refer sleeping sickness cases,
perhaps because they are not designated as sleeping sickness treatment centres. There
is therefore a need to regularly update the microscopists and the clinical workers in
these other health units about the diagnosis of sleeping sickness and to actively
involve them in the surveillance of sleeping sickness. Public-private partnerships in
the Uganda health services are being advocated (Birungi et al., 2001) and in this
regard, private health institutions may play an important role.
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The contribution of health care services has been highlighted as a necessity for a
sound and sustainable disease control policy. Moerman et al. (2003) observed that
assuming all interventions are cost-effective, their impact on mortality and morbidity
will only be marginal if access to proper care is not guaranteed and therefore, it is the
responsibility of scientists and health managers to highlight to policy makers and
donor agencies the importance of an accessible and well functioning health-care
system at all levels for the control of specific diseases. The present study emphasises
this by demonstrating the effects of distance to health unit on early case detection.
Some authors argue that Euclidean (straight line) distance is not an optimal measure
of accessibility (Shannon et al., 1973; Diechmann, 1997) because it does not take
into account physical barriers such as hills, rivers and the road network. Since a large
number of people either walk or use bicycles as their main form of transport,
Euclidean distances are a good proxy for accessibility in a rural population. Although
there is an overlap in the catchment areas of the three sleeping sickness diagnostic
centres beyond a 20 km radius, it is important to note that sleeping sickness reports
from the Lumino Health Centre 20 km catchment radius stopped after 1993 most
probably due to increased surveillance and treatment as well as tsetse control. In
addition, before 1989 and 1990 for Lumino and Busolwe hospitals respectively, LIRI
hospital was the sole sleeping sickness diagnostic centre. This may explain why most
cases were detected in time and place around LIRI hospital over the entire time
period. In the analysis, the problem of overlap is taken care of by including time and
centre in the model and by plotting separately the spatial effects on the proportion of
early stage cases for years when LIRI hospital was the only functional sleeping
sickness treatment centre, and other years; the trend was maintained in both analyses.
An independent association between young age and late stage presentation has also
been demonstrated perhaps because children and adolescents rely on the adults for
decisions to take the patients for treatment. Although sleeping sickness appears to be
more prevalent among the adults, it is important that health workers test children for
sleeping sickness in endemic areas. The apparent reduction in early case detection
during years of decreased incidence in a specific parish is indicative of annual parish
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incidence being an important temporal risk factor. This may be associated with
decreased awareness among the health workers and communities during periods of
low incidence. During such times, surveillance teams should have awareness
campaigns for all health workers and communities in areas where few patients are
being reported.
Since all sleeping sickness patients were included in the study, there is in principle,
no selection bias. Only patients with parasitological confirmation of trypanosomiasis
are treated as patients and therefore, all patients recruited into the study certainly had
sleeping sickness. Bias of misclassification is also unlikely because qualified and
long serving laboratory technicians were involved in the examination of CSF for the
staging of the disease. Although not found to be statistically significant, efforts must
be made to carry out active surveillance where there are many late cases, particularly
in areas not easily accessible to passive surveillance.
Emphasis on passive case finding is an approach suitable for T. b. rhodesiense and
not T. b. gambiense because the former is symptomatic while the latter is often
asymptomatic in the early stage (WHO, 1998) and therefore requires frequent active
screening using serological tests (Magnus et al., 1978). However, the GIS approach
in general, for mapping trends in sleeping sickness disease and sero-prevalence
distribution has been applied in T. b. gambiense areas (Cattand et al., 2002). The data
collected is then analysed to evaluate control operations such as case search,
diagnosis, treatment and vector control.
National and district health planners should aim towards high early sleeping sickness
patient detection at all health facilities. District health managers should regularly
geo-locate where sleeping sickness patients come from and position fixed-post
diagnosis at the nearest location to the current origin of the sleeping sickness
patients. Clinics reporting low percentage of early stage patients should be further
investigated to determine whether their quality of service differs from other clinics or
whether the differences are due to the distance sleeping sickness patients have to
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travel to the clinic. In Chapter 5, the health seeking behaviour among sleeping
sickness patients is examined.
In conclusion, since fixed post (passive) sleeping sickness patient finding is cheaper
than using active means, and that there are several fixed health units in the area, this
study demonstrates that great potential exists for improving health care provision for
sleeping sickness and thus, control of the disease in eastern Uganda. It also shows the
utility of GIS and the early to late stage case ratio in evaluating surveillance of
sleeping sickness. These surveillance tools and methodology are therefore advocated
for control programmes for targeting T. b. rhodesiense sleeping sickness.
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Chapter 5 Assessing health seeking behaviour among
sleeping sickness patients in eastern Uganda
5.1 Summary
To study the patterns of health seeking behaviour among sleeping sickness patients
in Eastern Uganda, data on socio-demographic and clinical characteristics, health
seeking behaviour and delays to presentation and diagnosis were collected from
diagnosed sleeping sickness patients. Analysis of odds ratios (OR) was used to
examine factors associated with delay. Among 119 patients, median total delay to
diagnosis was 2 months with service provider delay contributing a greater proportion
than patient delay. Patient and service provider delays were both independently
associated with sleeping sickness patients presenting in the late stage. The absence of
a blood examination test at the first visit is associated with service provider delay.
Most patients were referred to the sleeping sickness hospital by either the community
or on their own initiative and not by the health system. There is considerable delay
between symptom onset and diagnosis among sleeping sickness patients with a
median of 60 days. Substantial delay was attributable to the service provider failure
to diagnose sleeping sickness among symptomatic individuals. A deterministic
model structured on the possible routes of a sleeping sickness infection to either
diagnosis or death through the health system or out of it, showed that out of a total of
73 deaths, 62 (85%) entered the health care system but were not diagnosed, 11 died
without seeking health care from a recognised health unit while 62 (33 %) of the
remaining 186 died despite seeking appropriate health care. The sleeping sickness




Late stage presentation is associated with increased risk of death and transmission of
sleeping sickness. Therefore, understanding health seeking behaviour of rhodesiense
sleeping sickness patients is very important for sleeping sickness surveillance
programmes. Although studies of health seeking behaviour have been carried out in
other chronic diseases such as tuberculosis (Beyers et ah, 1994; Liam et al., 1997;
Lawn et al., 1998; Steen & Mazonde, 1998; Lonnroth et al., 1999; Sherman et al.,
1999; Wandwalo & Morkve, 1999; Salaniponi et al., 2000), similar studies on
sleeping sickness are lacking. A study of Trypanosoma brucei gambiense sleeping
sickness cases in the Democratic Republic of Congo observed that women tended to
present with less advanced disease than men probably due to differences in health
seeking behaviour (Pepin et al., 2002). Consequently, this study investigated the
health seeking behaviour among diagnosed sleeping sickness patients in eastern
Uganda where rhodesiense sleeping sickness is endemic. Its specific objectives were
to:
1. characterise a cross section of sleeping sickness patients;
2. determine the time between onset of symptoms and diagnosis of sleeping
sickness;
3. examine the relative contributions of patient and provider attributable delay;
4. describe patterns of health seeking behaviour to first presentation and to
diagnosis;
5. examine the association of socio-demographic, clinical and knowledge
factors to the time to first presentation and to diagnosis;
6. estimate the number and proportion of sleeping sickness cases who enter into
the health care system but are not diagnosed.
5.3 Materials and methods
5.3.1 Setting and population
This study was conducted in LIRI hospital, a sleeping sickness hospital in Tororo
district in the eastern region of Uganda, which is mainly a rural area with agro-
83
pastoral subsistence farming. In Tororo district, there are four hospitals, seven health
centres and several private clinics. Two of these hospitals treat sleeping sickness,
however, all of the hospitals and three health centres are equipped to diagnose the
disease. All sleeping sickness patients are admitted and registered at the time of
diagnosis. Clinical staging based on cerebrospinal fluid (CSF) findings was carried
out in all patients to decide on the treatment to be administered.
5.3.2 Patient identification and interview
A semi-structured questionnaire was administered to all patients (or attendants if the
patient was not capable of answering) who came for treatment between December
2000 and September 2002. A sleeping sickness patient was diagnosed by the finding
of trypanosomes either in his or her blood or CSF. The questionnaire covered the
following information: clinical symptoms such as fever, headache, body aches,
swelling of feet, dizziness, chancre and socio-demographic characteristics such as
age, sex, education level, occupation, ownership of radio or bicycle or cows, type of
house and tribe; perceptions of kind of illness, knowledge of trypanosomiais control
methods and facilities and trypanosomiasis control practices such as cattle treatment
and insecticide application; and health seeking behaviour characteristics such as type
of health unit first visited, source of money for costs accrued while ill, number of
visits to health centre before diagnosis, whether blood was examined at first visit,
who influenced going to sleeping sickness hospital, what the diagnosis was on the
first presentation, distance to sleeping sickness hospital and mode of travel to the
sleeping sickness hospital.
5.3.3 Definition of diagnosis delay
Patients were asked to estimate the time since they fell ill with the current diagnosis
of sleeping sickness. Total delay was defined as duration from onset of symptoms to
diagnosis. During the interview, the reasons for the total delay were explored. Patient
delay was defined as the time between the onset of symptoms to the first presentation
to a recognised health service provider. Health service provider delay was defined as
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the time between first presentation to diagnosis. Cut off times for categorising patient
delay was set at 14 days due to the severity of rhodesiense sleeping sickness with
patients expected to seek attention immediately and at 30 days for service provider in
case of a missed diagnosis at the first presentation. Home visits were made to
ascertain the information obtained from patients while in the hospital by interviewing
the heads of the homesteads and to geo-reference the homesteads so as to determine
accurately the distance travelled to LIRI hospital. Geo-referencing was carried out
using a Garmin 12 GPS receiver in WGS datum. Medical forms of the patients
obtained while attending other health units were read to objectively determine dates
and diagnoses made.
5.3.4 Data management and statistical analysis
Data, including both coded answers and text responses, were entered into Microsoft
Excel and analysis conducted in Epi Info 2002. Delay data in days are presented as
medians. Odds ratios (OR) and 95% confidence intervals (CI) were calculated in risk
analyses to investigate factors that may be predictive of patient delay and service
provider delay or late stage disease. Population attributable fractions (PAFs) of
factors significantly associated with service provider delay and PAFs of patient and
service provider delays for late stage occurrence were calculated to show how
important each of the significantly associated factors were in public health terms in
the population. PAF is the proportion by which the outcome (delay or late stage) may
be reduced if the factor were eliminated.
5.3.5 Quantification of undiagnosed deaths in the health-care system for
rhodesiense sleeping sickness
5.3.5.1 Model structure
A deterministic model structured on the possible routes of a sleeping sickness
infection to either diagnosis or death through the health system or out of it was
developed to quantify the number and proportion of undiagnosed deaths in the health
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care system for rhodesiense sleeping sickness during the diagnosis of the 119
sleeping sickness cases in this study (Figure 5.1).
The health-care system for rhodesiense sleeping sickness (SS) is modelled by using a
set of differential equations. In this section, a stage refers to the modelling stage, not
the clinical stage. Each patient starts as an early case in the community (Ec) and
follows one of the six possible routes as described below. In Route 1, an early case in
the community (Ec) reports to the health-care system and becomes an early-reported
case (Es), who eventually is diagnosed and treated as an early case (£>). In Route 2
and 3, an early case in the community (Ec) enters the health-care system as an early
case (Es), who subsequently becomes a late case of sleeping sickness while still in
the heath-care system (Ls\). In Route 2, a late case can be diagnosed and treated (Lr\)
whereas in Route 3, a late case might die from SS while still in the health-care
system (Ds\). In Route 4, an early case in the community (Ec) develops SS further
and becomes a late case (Lc), who subsequently dies from the disease while still in
the community (Dc). In Routes 5 and 6, an early case in the community (Ec)
becomes a late case (Lc), who then subsequently enters the health-care system as a
reported late case (Lsi). In Route 5, a patient enters the health-care system as a late
case (Lsi) and gets to be diagnosed and treated (Lti) whereas in Route 6, such a late
case dies from SS while still in the health-care system (Dsi)- Figure 5.2 summaries
the structure of the model. Times between the model stages have a notation Ty
denoting time from stage i to stage j.
T - / + T1
EcEt 1 ECES T ' EsEt (Route 1) (Equation 5.1)
(Route 2) (Equation 5.2)
(Route 3) (Equation 5.3)
(Route 4) (Equation 5.4)
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TE r, — TF . + T. , + T. ,CC^T2 c c LCLSl lS21jT (Route 5) (Equation 5.5)
TED ~ Tp i "t" Tw i + E, DtLCuSl ZCLC LCLS 2 LS2US2 (Route 6) (Equation 5.6)
Figure 5.1. Model structure for the sleeping sickness health-care system
E = early case, L = late case, C- community, S - health system, T = diagnosed and
treated, 1 = patients enter system as early, 2 = patients enter system as late, Tij = time
from model stage i to model stage j.
5.3.5.2 Modelparameters
The known parameters in the model are TE ,D, ECDS 108 days, the
time from stage Ec to Dc or Dsj or Ds2 i.e. mean duration to death from rhodesiense
sleeping sickness estimated from the mean duration of symptoms to death in patients
dying on admission due to sleeping sickness and not drug reactions (Odiit et al.,
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1997). The parameter TEcEs = 16 days is obtained from the mean duration to the first
visit to the health unit as reported by sleeping sickness cases diagnosed as early cases
among the 119 sleeping sickness cases recruited into the present study. Similarly, the
time TEsEt = 29 days is obtained from the same subset of the sleeping sickness cases
diagnosed as early cases and is the time from their first visit to the health care system
to diagnosis. The time TP , = Tr , = 94 is estimated from the mean duration ofC Li-p | titq L,-p 2
symptoms to diagnosis as a late case (Odiit et al., 1997). The final densities (end
outcomes) of the model structure Et = 45 and (Lti + Lt2) = 74 are obtained from the
119 rhodesiense sleeping sickness cases recruited into this study. Dc + Dsi + Ds2 =
78 (95% CI 72-85) is the estimate of unreported (undetected) deaths using the model
for estimating case under-detection in Chapter 2. The only unknown time interval is
TE L ■ It can be deduced that at the beginning of the model, there were
approximately 197 infections in the community, which is the total sum of all end
outcomes. Therefore, the initial conditions were Ec = 197, while all other outcomes
in the model had a population density of zero. The known parameters were then
entered into the model described.
5.3.5.3 Model dynamics
A model stage i has a population density of Nt (where i can either be Ec, Es, Et, Lq,
Ls\, Ls2, Lti, Lt\, Ln, Dc, Ds\ or Dsi). The rate of change in the population density
for stage i is modelled as:
dN
——L = Inj - Outi, (Equation 5.7)
dt
where In, and Out, are the rates of immigration into and emigration out of stage i
respectively. Assuming a stagej occurs before stage i, then In, is:
In, = rJtNj, (Equation 5.8)
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where rp is a parameter that measures the rate of transition from stages j to i, and Nj
is the population density of stage j. If a stage i is the origin of a route, then 7/r, is
equal to zero. Assuming a stage k occurs after stage then Outj is:
Out, = rlkN,, (Equation 5.9)
where r,k is a parameter that measures the rate of transition from stages i to k. If a
stage i is the end of a route, then Outj is equal to zero. If individuals in stage i can
either enter stages k or m, then Outj must include those entering stage k from stage i:
where rim is a parameter that measures the rate of transition from stages i to m. The
parameter measuring the transition rate between two stages, say fromj to i, is defined
as:
where 7}, is the time taken for an individual to move from stagej to stage i.
5.3.5.4 Model simulation
With estimated initial conditions and parameters, the model is simulated by solving
method (Press, 1992). The simulation is terminated once all the stages except those
in the end of each route (i.e. Ej, Lj\, Ln, Dc, An, As) have zero population
densities. The population densities of those stages in the end of each route are then
noted. From a range of values, the best estimate of the unknown time interval
7T , is selected to ensure that all the model end outcomes are consistent with theLSLS1
data used. This value is then used to estimate the number of deaths while in the
health care system (Ds\+ As?)-
Out, = r,kN, + r,mN,, Equation 5.10)
(Equation 5.11)
numerically the system of differential equations using the 4th order Runge-Kutta
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5.4 Results
127 sleeping sickness patients were interviewed during the study period. Eight
patients were later excluded from the analysis of patient or service provider delay
because of incomplete information on duration of illness.
5.4.1 Socio- demographic and clinical characteristics
The socio-demographic and clinical characteristics of the 119 sleeping sickness cases
included in the analysis are shown in Tables 5.1 and 5.2. The patients were mainly
(88.2%) greater than 14 years and 63.9% were males. Most patients were poor with
90.8% living in non-permanent housing structures (mud walls) and 92.4% without
salaried employment and dependant on subsistence farming. About half (54.6%) of
the patients owned a bicycle, a radio (56.3%), and/or cows (50.4%). About 85% had
not attained education beyond primary level. Most patients had symptoms with over
80% presenting with fevers, headaches, body aches or dizziness. However, history of
chancre lesions (41.2%) and/or swelling of the feet (37.0%) was reported by less than
half of the patients.
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Part time farmer 9 (7.6)
























*Head of household in case of children and adolescents
92
5.4.2 Perceptions, knowledge and practices
Perceptions, knowledge and practices among 119 sleeping sickness patients are
shown in Table 5.3. At the time of diagnosis, most (67.2%) patients thought they had
malaria, while the majority of the rest (16.8%) suspected AIDS. About 88.4% knew
that a tsetse bite is the cause of sleeping sickness. Two thirds of the respondents had
seen a sleeping sickness case before diagnosis. The patients were aware of the
existence of the sleeping sickness hospital (84.9%), the use of traps (95.0%), cattle as
a sleeping sickness reservoir (81.5%) but less than half (36.1%) were aware that
pour-on insecticides could be used for control of tsetse. Of the 59 patients'
homesteads that kept cattle, half (51.6%) reported having ever treated their livestock
for trypanosomiasis while only 10.2% had ever applied pour-ons (insecticides) on
their cattle.
5.4.3 Health Seeking Behaviour
Health seeking characteristics among sleeping sickness patients are presented in
Table 5.4. Most patients first reported to either a private clinic (43.7%) or public
health unit (health centre or hospital) (52.9%) with only one (0.8%) admitting that he
had first seen a traditional healer. However, 6 others reported visiting a traditional
healer at one time during their illness. Only 14 (11.8%) visited the health unit once
before diagnosis and treatment. The rest had to pay between 2 and 7 visits to health
units before they were diagnosed and treated. Blood examination was carried out in
45% of the patients during their first presentation to a recognized health unit. At first
presentation, most were diagnosed as having malaria (72.3%) while 19.3% were
diagnosed as having sleeping sickness. Only 22.6% were referred to the sleeping
sickness hospital by either the public (11.7%) or private health system (10.9%) while
the rest (77.4%) either decided on their own or were influenced by family members,
neighbours, local leaders and organizations to think they had sleeping sickness. Only
one fifth of these patients came from within 5 km of the sleeping sickness hospital
but 73.2% were carried to the hospital on their own or hired bicycles (69.8%) or by
93
foot (3.4%). Funds to cover the SS related health care were mainly (54.7%) obtained
through sale of agricultural produce.
Table 5.3. Perceptions, knowledge and practices among rhodesiense sleeping
sickness cases
Variable number (percent)
Perception of kind of illness





Cause of sleeping sickness
Tsetse bite 104 (87.4)
Other 15 (12.6)
Seen a sleeping sickness case before
Yes 78 (65.5)
No 41 (34.4)
Aware of sleeping sickness hospital
Yes 101 (84.9)
No 18 (15.1)
Aware of potential reservoir status of cattle
Yes 97 (81.5)
No 22(18.5)
Aware of tsetse traps
Yes 113 (95.0)
No 6 (5.0)
Aware of pour-ons for tsetse control
Yes 43 (36.1)
No 76 (63.9)






*Only homes with cattle
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Table 5.4. Health seeking behaviour characteristics
Variable number (percent)






Source ofmoney for health expenses
Sold agricultural produce (chicken, goats
crop produce etc) 64 (54.7)
Other (children, salary, NGOs etc) 55 (45.3)






Blood examined at first presentation
Yes 53 (44.5)
No 66 (55.5)





Public health system 14 (11.7)
Private health system 13 (10.9)
Other 2 (1.6)
Diagnosis at first presentation
Malaria 86 (72.3)
Sleeping sickness 23 (19.3)
Other 10(8.4)
Distance of patients home from SS hospital
0-5km 24 (20.2)
>5 to 10 km 70 (58.8)
>10 to 20km 11(9.2)
>20km 14(11.8)





Estimates of patient delay and service provider delay are shown in Table 5.5.
Applying the definitions given above for patient delay and service provider delay,
52.1% and 50.4% of the patients had patient and service provider delays respectively.
The median patient, service provider and total delays were two and half weeks, one
month, and two months respectively.








Median patient delay 17 days (Two and a half weeks)
Median service provider delay 30 days (One month)
Median total delay 60 days (Two months)
Odds ratios (OR) for analyses of patient and service provider delays for associated
factors are presented in Table 5.6. Of all factors tested, blood not being examined at
the first presentation, was significantly (.P<0.05) associated with service provider
delay (OR 0.45, 95% CI 0.22-0.95) and not staying in a permanent house was
significantly (p<0.05) associated with patient delay (OR 0.18, 95% CI 0.02-0.93). In
Table 5.6 factors associated with patient delay are shown. Both patient and service
provider delays were each significantly (P<0.05) associated with a patient being
diagnosed in the late stage. The OR for patient delay was 2.98 (95% CI 1.38-6.43)
while that for service provider delay was greater at 7.29 (95% CI 3.1-17.14). The
results show that having a blood examination on the first visit will reduce service
provider delay by as much as 38% (PAF), while living in a non-permanent house is
associated with 70% (PAF) of the patient delay. Elimination of service provider
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delay would result in an 80% (PAF) reduction in late stage presentation while
elimination of patient delay will result in a 55% (PAF) reduction in late stage
occurrence.
Table 5.6. Factors associated with "patient delay" and "service provider delay"
Patient delay Service provider delay
FACTOR OR (95% CI) (PAF) OR (95% CI) (PAF)
Blood examined
on first presentation NA 0.45 (0.22-0.95) (38%)
Permanent house 0.18 (0.02-0.93) (70%) NA
Late stage 2.98 (1.38-6.43) (55%) 7.29 (3.1-17.14) (80%)
OR = Odds Ratio, CI = Confidence Interval, PAF = Population Attributable Fraction,
NA =Not applicable
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In Figure 5.2 the trends in total, patient and service provider delays are compared to
the proportion of early and late stage cases. At one to two months of total delay, the
proportion of early stage cases is 53.8%.
Figure 5.2. Trends in total, patient and provider delays and proportions of early stage
cases
ISsBSI Patient Delay











There is no significant association between patient and service provider delays
indicating that they were independent of each other (Table 5.7).
Table 5.7. Relationship between patient and service provider delays
Patient Delay Provider delay
No Yes
No 34 (59.6%) 23 (40.4%)
Yes 25 (40.3%) 37 (59.7%)
P>0.05
Socio-demographic, clinical and knowledge factors were not found to be
significantly associated with visiting health units for a maximum of two times before
being diagnosed (Tables 5.8, 5.9 and 5.10). However, blood examined on the first
visit to a health unit or paying a first visit to a public health unit were significantly
(P<0.05) associated with diagnosis within two visits to a health unit (Table 5.11).
Nonetheless, using multivariate analysis, it was found that of these two significant
variables, blood examined on the first visit to a health unit remained as the only
significant (p<0.05) variable.
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Table 5.8 Socio-demographic risk factors for visiting a health unit for a maximum of
two times before diagnosis of sleeping sickness
Variable No of visits OR CI P
<2 >2
Age
0-19 years 7 26 0.6 0.2-1.4 >0.05
> 20 years 28 58
Sex
Female 13 30 1.1 0.5-2.4 >0.05
Male 22 54
Education status*
Primary or less 22 60 0.7 0.3-1.6 >0.05
Secondary 13 24
Tribe
Adhola 13 46 0.5 0.2-1.1 >0.05
Other 22 38
Religion
Catholic 18 45 0.9 0.4-2.0 >0.05
Other 17 39
House type
Non-permanent 31 77 0.7 0.2-2.6 >0.05
Permanent 4 7
Bicycle in home
Yes 18 47 0.8 0.3-1.8 >0.05
No 17 37
Cows in home
Yes 23 37 2.4 1.0-5.5 >0.05
No 12 47
Radio in home
Yes 22 45 1.5 0.7-3.3 >0.05
No 13 39
Employment*
Part time farmer 1 4 0.4 0.0-3.5 >0.05
Full time farmer 22 32
*Head of household in case of children and adolescents
OR = Odds Ratio, CI = Confidence Interval, P= significance
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Table 5.9. Clinical risk factors for visiting a health unit for a maximum of two times
before diagnosis of sleeping sickness
Variable No of visits OR CI P
<2 >2
Chancre
Yes 19 30 2.1 1.0-4.8 >0.05
No 16 54
Fever
Yes 35 79 - - >0.05
No 0 5
Headache
Yes 32 81 0.4 0.1-2.1 >0.05
No 3 3
Generalised body aches
Yes 33 78 1.3 0.2-6.6 >0.05
No 2 6
Dizziness
Yes 27 71 0.6 0.2-1.9 >0.05
No 6 10
Swelling of feet
Yes 10 34 0.6 0.2-1.7 >0.05
No 25 50
Weakness
Yes 22 33 2.0 0.9-20.0 >0.05
No 1 3
Weight loss
Yes 19 28 1.4 0.4-5.2 >0.05
No 4 8
Aware of live bait
Yes 13 30 1.1 0.5-2.6 >0.05
No 22 54
Seen SS case before
Yes 22 56 0.9 0.4-1.9 >0.05
No 13 28
OR = Odds Ratio, CI = Confidence Interval, P= significance
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Table 5.10. Knowledge risk factors for visiting a health unit for a maximum of two
times before diagnosis of sleeping sickness
Variable No of visits OR CI P
<2 >2
Aware of traps
Yes 32 81 0.4 0.1-2.1 >0.05
No 3 3
Aware of SS reservoir potential of cattle
Yes 29 68 1.1 0.4-3.2 >0.05
No 6 16
Aware of SS hospital
Yes 28 73 0.6 0.2-1.7 >0.05
No 7 11
Aware of tsetse traps
Yes 32 81 0.4 0.1-2.1 >0.05
No 3 3
Treated cows for nagana
Yes 11 19 0.8 0.3-2.3 >0.05
No 12 17
Used live bait
Yes 3 3 1.7 0.3-9.0 >0.05
No 20 33
OR = Odds Ratio, CI = Confidence Interval, P= significance
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Table 5.11. Treatment seeking risk factors for visiting a health unit for a maximum
of two times before diagnosis of sleeping sickness
Variable No of visits OR CI P
<2 >2
*Blood examined on first visit
No 7 59 0.1 0.0-0.3 0.01
Yes .28 25
Mode of travel to SS hospital
Walk or bicycle 24 61 0.7 0.3-1.7 >0.05
Vehicle 11 20
**Type of health unit first visited
Private 10 42 0.4 0.2-0.9 0.05
Public 25 41
Distance from SS hospital
0-10km 30 64 1.9 0.6-5.4 >0.05
10 km
*Remained significant on multivariate analysis
** Not significant on multivariate analysis
OR = Odds Ratio, CI = Confidence Interval, P = significance
5.4.4 Undiagnosed deaths in the health system
Running the model with known parameters enables the estimation of the following
unknown parameters: TEcLc = 32 days; TLcLs2 = 16 days; Tesls2] = 16 days, Dsi = 38
deaths; Ds2 = 24 deaths; and Dc = 11 deaths. Therefore the model estimates a total of
73 deaths which is within the 95% Confidence Interval for the estimates of
undiagnosed deaths estimate by the model for estimation of under-detection outlined
in Chapter 2. Out of a total of an estimated undetected 73 deaths, 62 (85%) entered
the health care system but were not diagnosed. Out of 197 initial infections, 11 died
without seeking health care from a recognised health unit. Therefore 62 (33 %) of the
remaining 186 died despite seeking appropriate health care.
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5.5 Discussion
Delayed diagnosis of sleeping sickness is likely to be associated with a worse
prognosis, and of particular public health importance, delay of treatment of sleeping
sickness is likely to be associated with an increased number of newly infected
persons caused by the initial infected person. This study shows that there is
considerable delay between onset of symptoms and diagnosis among sleeping
sickness patients in eastern Uganda. While patient delay contributes substantially to
late patient presentation, an important preventable period of morbidity in the
community was caused by failure of recognized health services to diagnose sleeping
sickness among symptomatic patients. In addition, approximately 85% of the patients
that die undiagnosed do enter the health system but are not detected and one third of
those that do enter the health system die undiagnosed. This emphasises the need to
improve case detection.
There are some limitations to the information collected. Patient recall of the duration
of illness may not be that accurate, especially in longer illnesses, despite the repeated
probing to validate responses. However, the findings of a strong correlation between
clinical late staging and duration of illness indicates that the accuracy of duration of
illness reported by patients was adequate for purposes of defining delay. It is also
assumed that all delays after the initial presentation at a health unit is due to service
provider, whereas some could have been due to patient factors. However, diagnosis
of sleeping sickness or referral of patients to the appropriate hospital, if done by the
provider at the first presentation, will most certainly have reduced service provider
delay. In addition, there was no significant association between service provider and
patient delay.
This study indicates that the use of private clinics as the first contact of a recognized
health service is important. Referrals by these clinics, however, were only made by a
few. On the other hand, the community (neighbours, family and self) were
instrumental in referral of the patients to the sleeping sickness hospital. Therefore,
timely sensitization of the affected communities during outbreaks may improve
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sleeping sickness surveillance. Radio has been identified as a most reaching out
media in Soroti district (Susanna Thorpe, Wren Media, personal communication) and
can be used for this purpose. Another potential way of involving sleeping sickness
patients in control of the disease, is through control of the sleeping sickness reservoir
in cattle and in tsetse flies by treating cattle with trypanocides and applying pour-on
insecticides to cattle to control tsetse, since half of the patients kept cattle in their
homesteads. The need for community consultations before designing health
programmes has also been observed in the context of malaria transmission and has
been highlighted in another study conducted in a rural population in Uganda
(Kengeya-Kayondo et al., 1994). The findings of that study suggested that without
prior research, malaria programmes which aim at vector control and early diagnosis
and treatment of cases may prove ineffective and that information, education and
communication programmes should be designed, implemented and evaluated with
the full participation of the target population at every stage.
In Chapter 4, it has been shown that there is an association between clinical stage
(early/late) and increased distance to diagnostic health facility, especially beyond 20
km. However, in this study, most patients came from within 20 km of the sleeping
sickness hospital. Although 80% of the patients came from Euclidean distances of
greater than 5 km, the recommended health care coverage distance, more than 70%
travelled on bicycles or walked to the sleeping sickness hospital.
Studies of health seeking behaviour among sleeping sickness patients are difficult to
obtain in the literature. However, health seeking behaviour studies in other chronic
diseases such as tuberculosis have been reported widely (Sherman et al., 1999;
Wandwalo & Morkve, 1999; Salaniponi et al., 2000). In these studies, patient delay
is frequently more than service provider delay, perhaps because chronic cough is
quite easily associated with tuberculosis compared to the non-specific
symptomatology of sleeping sickness. In a study conducted on sleeping sickness data
from the Democratic Republic of Congo, women were found to be more likely to
have less advanced disease than men (Pepin et al., 2002). The plausible explanation
was that women might have better health seeking behaviour than men. This
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explanation is supported by another study in Cameroon that showed that in general,
women tend to participate more keenly in case-finding sessions aimed at detecting
sleeping sickness cases among the asymptomatic population (Asonganyi & Ade,
1994). However, in this study, sex was not associated with diagnosis delay, most
probably because T. b. rhodesiense sleeping sickness case-finding is mainly at fixed-
post (passive) health units rather than through active case-finding as is carried out for
T. b. gambiense sleeping sickness (WHO, 1998).
The findings of this study suggest that one important way of reducing delays in
diagnosis among rhodesiense sleeping sickness patients is improvement of
investigation and referral of patients presenting with symptoms at the primary care
level. This study revealed that nearly all patients use recognised health units as their
first contact. Only 42% were appropriately managed, that is, sleeping sickness
diagnosis was made (19.3%) or referral to a sleeping sickness hospital (22.7%) took
place. Approximately two-thirds of the patients presented to the sleeping sickness
hospital after self-referral or insistence of the patient's family members and
neighbours. Often it is the government health units that are better equipped with
microscopes, and this explains the significant association between government health
units and sleeping sickness diagnosis. Patients from homes that had permanent house
structures represent a more wealthy and informed population and therefore are more
likely to seek health care earlier than the poorer population.
In conclusion, this treatment seeking behaviour study has revealed that, in addition to
increasing awareness of the communities, the health system outside the traditional
sleeping sickness treatment centres should become more involved in sleeping
sickness control and made aware of the existence of sleeping sickness when an
outbreak is occurring. They can then refer the patients and suspected sleeping
sickness patients to the established sleeping sickness treatment centres for
appropriate management. Sleeping sickness control programmes can set up
geographically sensitive health information systems that are efficient and responsive
to the local endemic condition by carrying out operational research on the treatment
seeking behaviour of the target population. In this way, delays in sleeping sickness
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diagnosis will be reduced. In the longterm, cheap and simple diagnositics should be
developed.
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Chapter 6 Spatial and spatio-temporal trends of T. b.
rhodesiense sleeping sickness in Tororo and Busia districts,
Uganda, from 1987 to 2001
6.1 Summary
Trypanosoma brucei rhodesiense sleeping sickness is a fatal epidemic-prone
protozoal zoonotic disease transmitted by an arthropod vector, Glossina, occuring in
foci in sub-Saharan Africa. However, the analytical description of spatial and
temporal occurrence of the outbreaks at control implementation levels is lacking. The
presence of spatial and temporal clusters may indicate a common time and place
transmission of the same parasites within the mammalian-fly cycle, thus presenting
an opportunity for targeted control. This study looked for evidence of significant
spatial temporal clustering of sleeping sickness cases at village level. A total of 1316
sleeping sickness reported patients from Tororo and Busia districts between 1987 and
2001 were analysed. The spatial distribution was analysed by applying the SaTScan
method to determine if there was spatial and spatial-temporal clustering of sleeping
sickness. Significant village scale spatial and spatial-temporal clustering of sleeping
sickness was observed after initial occurrence of a few cases and persisted in and
around villages where there was none or delayed control intervention.
Implementation of control of tsetse and that of the cattle reservoir of sleeping
sickness was not timely responsive to prevent spread of the disease but reduced the




Sleeping sickness is reported to be endemic in several countries in Africa (WHO,
1999b). However, the distribution of sleeping sickness in these countries is very
focalised. Most studies of the distribution of sleeping sickness and tsetse have been
at continental level (Rogers & Randolph, 1989). The geographic distribution of
rhodeisense sleeping sickness (RSS) is limited by the distribution of vector and
reservoir hosts with foci occurring within these limits. The south-east of Uganda
where the species of tsetse G. f. fuscipes is found has long been considered the focus
of RSS (Mackichan, 1944; Robertson, 1958; Ormerod, 1961; Abaru, 1985;
Mbulamberi, 1989). Although, the focalisation of sleeping sickness is acknowledged
(WHO, 1998), there have been no cluster analysis studies like those carried out on
the distribution of cancers (Kulldorff & Nagarwalla, 1995; Hjalmars et al., 1996)
with the exception of an out break in Soroti (Fevre et al., 2001). Neither have these
residual foci been accurately mapped (Scott, 1970). The possible aetiological factors
explaining the occurrence of clustering are related to human-fly contact.
Peridomestic breeding sites of G. f. fuscipes in a sleeping sickness focus in Busoga,
Uganda were identified in coffee and banana plantations, and in L. camara thickets
and around houses (Okoth, 1986).
The eco-epidemiological pattern of sleeping sickness is complex and interactions
between several potential spatial and temporal factors are responsible for their
complexity. These factors include movement of infected livestock into the tsetse-
infested districts (Fevre et al., 2001), political and economic upheavals with no
control operations (Mbulamberi, 1989) and increasing contact of the population with
the vector through encroachment of the tsetse habitat as a result of the ever-growing
population. As a result of these interactions, various sizes of epidemics of sleeping
sickness, a disease classified as epidemic-prone, may occur (WHO, 2002). Due to
these complex interactions and varying magnitudes of the sleeping sickness public
health problem, continuous monitoring of temporal and spatial trends is important so
as to tailor control measures to the current local situation and to evaluate the impact
of control.
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In eastern Uganda, the sleeping sickness epidemic that occurred from 1976
eventually spread to Tororo and Busia districts in the late 1980s to the early 1990s
(Lancien et al, 1990; Enyaru et ah, 1992). Various control methods were put in place
in Tororo and Busia districts (Lancien, 1991; Okoth et al., 1991; Magona et ah,
1998) to contain the epidemic. The broad objective of this study was to describe the
spatial and temporal trends of sleeping sickness over a period of 15 years using
sleeping sickness case records of patients from Tororo and Busia districts.
Specifically, the objectives were as follows:
1) To map the spatial and temporal trends of sleeping sickness;
2) To determine if there was significant village scale spatial and temporal
clustering of sleeping sickness;
3) To compare the lengths of occurrence of disease in areas with or without
control
By quantifying the annual space clustering of all reported cases in the health units in
the study area, occurrence and risk of local transmission can be evaluated. This
information and methods are of use to the district sleeping sickness control
programmes in evaluating the impact of surveillance and control efforts.
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6.3 Materials and methods
6.3.1 Study design
A cross sectional study of villages that have reported sleeping sickness in Tororo and
Busia districts from 1987 to 2001 was carried out by examining sleeping sickness
records, mapping and analysing disease distribution.
6.3.2 Study area
The study area consisted of Tororo and Busia districts. South-eastern Uganda is
drained by the source of the river Nile and its tributaries between the lakes Victoria
and Kyoga. Tororo and Busia districts are found along the eastern border of Uganda
(Figure 3.1). The total population of Tororo and Busia districts in the 1991 census
was 555,674 and was estimated to be growing at a rate of 2.5 percent per annum
(MOF, 1992). The population is a mixture of the Nilotic, Nilo-hamitic and Bantu
tribes. The main occupation is small-scale mixed farming with subsistence growing
of food crops and livestock rearing. Farmers rear cattle, goats, pigs and sheep and
poultry. The types of crops grown are maize, millet, groundnuts, cassava, sweet
potatoes and rice in these two districts. Drugs for the treatment of sleeping sickness
are provided free of charge by the ministry of health. Suramin is used to treat the
early stage of the disease and Melarsoprol is used to treat the late stage. The Ministry
of Health is the sole supplier of these drugs and they can only be administered in
prescribed health units. Tsetse are controlled by use of impregnated pyramidal traps
(Lancien, 1991). A sleeping sickness control programme, co-funded by the Uganda
government, European Economic Community (EEC) (Lancien et al., 1990, Lancien,
1991) and the Organization of African Unity Inter-African Bureau of Animal
Resources (OAU/IBAR) (Magona et al., 1998) was implemented from 1987 to 1997




Data on confirmed sleeping sickness cases from LIRI and Busolwe hospitals as well
as Lumino Health Centre during the period 1987-2001 were obtained from the
Ministry of Health. The patient records included information on the village of origin
and date of admission.
6.3.3.2 Demographic and geographic data
All available data on location and year of diagnosis of sleeping sickness was entered
into a geographic database, with a degree of spatial precision at village level.
Population data for village levels was obtained from the 1991 population census
(MOF, 1992). Latitude and longitude coordinates for all villages listed in the census
data were geo-referenced using a Global Positioning System (GPS) to the centre of
settlement in the village. The ArcView GIS software package (ESRI corporation,
NY) (ESRI, 1998) is used to produce maps of village sleeping sickness case
numbers, sleeping sickness village clusters and area of tsetse control measures.
6.3.4. Chronology of sleeping sickness control intervention
The years of application of sleeping sickness control measures, in particular areas in
Tororo and Busia districts were obtained from minutes of the monthly sleeping
sickness control project meetings and from publications (Lancien et al., 1990;
Lancien, 1991; Okoth et al., 1991; Magona et al, 1998). The major intervention was
tsetse control by insecticide impregnated pyramidal traps with a few instances of
ground spraying of insecticides and application of pour-ons on cattle. Selective
treatment of cattle on the basis of demonstration of parasites by microscopy was also
carried out. The annual trends in number of sleeping sickness cases that reported
more than 10 cases between 1987-1999 were plotted on graphs.
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6.3.5 Data analysis
The location and time of significant space-time clusters in the villages of Tororo and
Busia districts were analysed using the spatial-scan statistic of the software SaTScan
(Kulldorff & Nagarwalla, 1995). This was done for the period from 1987 to 2001.
This spatial-scan statistic locates the centre and radius as well as the period of
significant clustering. The probability model used in SaTScan was based on a
Poisson distribution. A Poisson model was used in the spatial scan because the
background population represented a certain risk mass. This statistic adjusts for the
heterogeneity of the underlying population and detects clusters of any size located
anywhere in the study region regardless of their shape. SaTScan searches iteratively
for case clusters using a continuously variable, circular window size to detect spatial
clusters in large areas, while controlling for the underlying population structure
(Kulldorff & Nagarwalla, 1995; Hjalmars et al., 1996). To test for spatial clustering
by year, the spatial scanning window was set at a maximum spatial cluster size of 50
percent of the total population in the study area. While to test for spatial-temporal
clustering throughout the study period, the spatial scanning window was set at a
maximum spatial cluster size of 20km radius to give a diameter of approximately
half the length of the study area. The temporal scanning window was set at 72
months because this was the maximum number of consecutive years that a village
reported sleeping sickness (Figure. 6.2). The cluster was centred at any of the village
locations in the initial analysis for clustering. A likelihood ratio is calculated for each
circle for the alternative hypothesis that there is an increased risk of disease within
the circle against the null hypothesis that the risk inside the circle is the same as the
risk outside it. The most likely cluster is that with the largest likelihood ratio. The
statistical significance of this largest likelihood ratio is assessed by determining its
distribution under the null hypothesis through Monte Carlo simulation (1000
simulations performed). This takes care of the problem of multiple testing associated
with the method due to searching for the most suitable village position as a cluster
centre. Secondary clusters were only determined if their radii were not overlapping.




6.4.1. Description of sleeping sickness reported incidence
In Tororo and Busia districts, 1316 T. b. rhodesiense sleeping sickness cases were
reported between 1987 and 2001, from LIRI and Busolwe hospitals and Lumino
Health Centre. The annual incidence of sleeping sickness from 1987 to 2001 showed
two peaks at the beginning and end of the period (Figure 6.1). The reduction in the
first peak corresponded to the period of the donor -funded sleeping sickness control
project and occurred after the cessation of donor-funded control.
Figure 6.1. Annual number of sleeping sickness cases and years of donor funded
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6.4.2. Spatial and spatio-temporal clustering of sleeping sickness cases
Generally, there was significant (P<0.05) spatial clustering of sleeping sickness in all
years from 1987 to 2001 in Tororo and Busia districts and the clusters and their
relative risks (RR) for sleeping sickness are shown in Figures 6.2 to 6.16. The spatial
clusters in the early years (1987 to 1988) (Figures 6.2 and 6.3) were of small radii (<
5 km). However, the cluster sizes increased in 1989 to 1990 to 34 km and 44 km
(Figures 6.4 and 6.5) showing the quick expansion of high rates of transmission
within 3 years. In 1991, the large size cluster split into two small clusters, probably
due to the application of control measures (Figure 6.6) meanwhile two other clusters
occurred. From 1992 to 1996, significant sleeping sickness clustering mainly
occurred at the northern edge of the control area but the disease was apparently under
control south of the clustering where control measures had been in place for longer
(Figures 6.7 to 6.11). From 1997 to 1999, clustering occurred outside the area control
had been implemented but had since stopped (Figures 6.12 to 6.14). During these
years, the disease appeared to be under control in the controlled area. From the year
2000 (Figures 6.15 to 6.16), sleeping sickness occurrence and clustering was again
observed where it first occurred in 1987 and 1988 and the cluster size had increased
by year 2001 when control interventions resumed. During the same period (2000 to
2001), the disease persisted in areas where no control intervention had been applied
at all. Spatio-temporal clustering occurred from 1998 to 2001 in the north west of the
study area and in 2001 in the eastern part of the area Figure 6.17 suggesting new
resurgences that may result in larger outbreaks if not controlled effectively.
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Figure 6.2. Spatial distribution of sleeping sickness cases by village and of
significant clusters in 1987
The relative risk (RR) of infection within the cluster is shown.
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Figure 6.3. Spatial distribution of sleeping sickness cases by village and of
significant clusters in 1988
The relative risk (RR) of infection within the cluster and the area under control is
shown.
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Figure 6.4. Spatial distribution of sleeping sickness cases by village and of
significant clusters in 1989
The relative risk (RR) of infection within the cluster and the area under control are
shown.
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Figure 6.5. Spatial distribution of sleeping sickness cases by village and of
significant clusters in 1990
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Figure 6.6. Spatial distribution of sleeping sickness cases by village and of
significant clusters in 1991
The relative risk (RR) of infection within the cluster and the area under control are
shown.
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Figure 6.7. Spatial distribution of sleeping sickness cases by village and of
significant clusters in 1992
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Figure 6.8. Spatial distribution of sleeping sickness cases by village and of
significant clusters in 1993
The relative risk (RR) of infection within the cluster and the area under control are
shown.
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Figure 6.9. Spatial distribution of sleeping sickness cases by village and of
significant clusters in 1994
The relative risk (RR) of infection within the cluster and the area under control are
shown.
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Figure 6.10. Spatial distribution of sleeping sickness cases by village and of
significant clusters in 1995
The relative risk (RR) of infection within the cluster and the area under control are
shown.
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Figure 6.11. Spatial distribution of sleeping sickness cases by village and of
significant clusters in 1996
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Figure 6.12. Spatial distribution of sleeping sickness cases by village and of
significant clusters in 1997
The relative risk (RR) of infection within the cluster is shown.
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Figure 6.13. Spatial distribution of sleeping sickness cases by village and of
significant clusters in 1998
The relative risk (RR) of infection within the cluster is shown.
RR=60.5, P<0.05
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Figure 6.14. Spatial distribution of sleeping sickness cases by village and of
significant clusters in 1999
The relative risk (RR) of infection within the cluster is shown.
| | 1999 cluster radius
Cluster centre
% 1999
[~n Tororo and Busia boundary
+ SS health unit







Figure 6.15. Spatial distribution of sleeping sickness cases by village and of
significant clusters in 2000
The relative risk (RR) of infection within the cluster is shown.
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Figure 6.16. Spatial distribution of sleeping sickness cases by village and of
significant clusters in 2001
The relative risk (RR) of infection within the cluster and the area under control are
shown.
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6.4.3. Lengths of occurrence of sleeping sickness in villages with or without
control
176 (61%) of the villages that reported sleeping sickness did so for one year, 216
(75%) for within a maximum of two consecutive years between 1987 and 1999
(Figure 6.18). One village reported sleeping sickness for 6 consecutive years and was
in an area where there was no tsetse control intervention. During the same period,
288 villages reported sleeping sickness cases. Out of the 288 villages, 91 (32%)
reported only one case of sleeping sickness during the period under review (Figure
6.19). Three villages reported over 35 cases while 27 villages reported more than 10
cases. Figures 6.20-6.24 are graphs of trends of numbers of sleeping sickness cases
in villages that reported more than 10 sleeping sickness cases. The reduction in
number of cases was greater and quicker in villages where tsetse control was applied
when compared to where there was no tsetse control and the disease resurged earlier
in areas where there was no control at all (Figures 6.20 to 6.26). Figures 6.2 to 6.16
are maps showing the spatial distribution of sleeping sickness cases by village, of
significant clusters and areas of application of control. These figures show that
villages where no tsetse control intervention was applied continued to report sleeping
sickness until 1999 while all villages where tsetse control was applied ceased to
report sleeping sickness after 1994. In addition, villages where tsetse control was
applied did not report sleeping sickness for more than 4 years post-application of the
control (Figure 6.26).
132
Figure 6.18. Frequency of villages by number of consecutive years of reported cases
by village in Tororo and Busia districts, 1987-1999
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Figure 6.20. Number of SS cases by year and types of tsetse control in villages that
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Figure 6.21. Number of SS cases by year and types of tsetse control in villages that
reported more than 10 cases (Magoro, Poniara, Pokach, Malawa, Yoboke and Paloto)
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Figure 6.22. Number of SS cases by year and types of tsetse control in villages that
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Figure 6.23. Number of SS cases by year and types of tsetse control in villages that
reported more than 10 cases (Pajwenda, Kisote, Busabi, Liyonga-Wagunga,
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Figure 6.24. Number of SS cases by year and types of tsetse control in villages that
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Figure 6.25. Total number of sleeping sickness cases by year and type of tsetse
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Figure 6.26. Total number of sleeping sickness cases by year in villages that




This study aimed at contributing to a better comprehension of the trends of T. b.
rhodesiense sleeping sickness by analysing the spatial and temporal distribution in
Tororo and Busia districts of 1316 cases of the disease in the period 1987 to 2001.
The datasets used in this study are based mainly on passive detection of the cases.
Although, they may not estimate the true incidence of the disease in Tororo and
Busia districts, they are useful in giving an indication of infection trends and an
estimate of the efforts necessary to control sleeping sickness and can reveal changing
geographical patterns of the disease.
The annual number of sleeping sickness cases in Tororo and Busia districts varied
from year to year over the 15 years but generally, there were peaks at the beginning
(1988 to 1992) and end of the period (2001) separated by a period with relatively low
numbers. Although intervention did appear to reduce the incidence of sleeping
sickness, similar but less dramatic reductions were observed in areas where there was
no tsetse control intervention at all. However, areas where there were not tsetse
control operations had a resurgence of the disease earlier than where there was no
control at all suggesting a longer-term benefit of tsetse control. Similarly, areas
where there had been under tsetse control began reporting sleeping sickness once the
control operations ceased but not for several years. There is an association between
the resurgence of sleeping sickness and the cessation of donor-funded control of the
disease (Lancien et al., 1990, Lancien, 1991; Magona et al., 1998). A sleeping
sickness control project funded by the European Economic Community (now known
as European Union) and the Organization of African Unity Inter African Bureau for
Animal Resources (OAU/IBAR) was in place from 1988 to 1997. This emphasises
the need for commitment of resources to by endemic governments and development
sleeping sickness strategies that are less donor dependent, i.e., affordable, acceptable
and effective. Currently, the major control strategies for sleeping sickness in Uganda
are case finding and treatment, tsetse control using insecticide impregnated traps and
live-baits and treatment of cattle with trypanocidal drugs because livestock have been
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proven to be an important reservoir of the disease (Onyango et al., 1965; Hide et al.,
1994; Fevre et al., 2001). These activities are once again being supported by a
European Union funded project called "Farming in Tsetse Control Areas of Eastern
Africa (FITCA). Studies examining ways of encouraging communities to participate
in these control strategies are necessary to ensure continuity in the absence of donor
supported control activities. In Chapter 6, opportunities for involving communities in
case finding, control of the cattle sleeping sickness reservoir and vector control
through use of live baits (insecticides applied to cattle) are determined. During this
epidemic, selective treatment of cattle based on microscopy for trypanosomes was
carried out. There is now evidence that traditional parasitological methods by
microscopy have very low sensitivity when compared to polymerase chain reaction
(PCR) testing (Picozzi et al., 2002). This indicates that block treatment of all cattle
may be justifiable after parasitological detection of trypanosomes in a small cross
section of the cattle population. Block treatment may result in quicker control of
sleeping sickness clusters.
The distribution of sleeping sickness shows significant clustering in all years from
1987 to 2001. It is apparent that sleeping sickness outbreaks rarely lasted longer than
one year in any single village perhaps because sleeping sickness has a low basic
reproductive rate (Rogers & Williams, 1993). However, in areas where sleeping
sickness control intervention were not applied, the disease persisted in villages for
much longer and significant clusters of sleeping sickness did develop, and tended to
spread locally. Clustering would occur after an initial occurrence of a few isolated
cases and before the initiation of a definite control programme for the affected areas
emphasising the necessity of having a control programme that is timely responsive to
the occurrence of even a single case. This also means that it is necessary to have
sensitive disease surveillance structures to detect the disease occurrence at the
earliest possible stage but complemented by timely responsive sleeping sickness
control interventions. Tsetse control operations using impregnated traps are generally
complex requiring a lot of planning and resources and this may explain the delays in
action resulting in the clustering of sleeping sickness occurrence before any action
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was taken. More rapid methods of intervention need to be applied to prevent
consolidation and spread of the disease.
Most of the cases occurred around the basins of the rivers Osia and Malaba basins
(Figure 4.1). However, the reporting effect of the proximity of a sleeping sickness
hospital to these rivers must be considered. In Chapter 7, the distribution of villages
that reported sleeping sickness during the period under review and those that did not
is examined in relation to the distance to the main sleeping sickness hospital. It is
possible that the clustering seen around the hospital may have been due to increased
chance of diagnosis for patients in nearer villages. However, there were clusters
observed elsewhere further away from the sleeping sickness diagnostic facilities. The
place of residence at onset of illness of a patient was used to determine the affected
villages because it was most reasonably the likely origin of infection since movement
of people in this area is quite limited.
The predominance of villages reporting a few patients for only a short time suggests
that cow-to-man transmission may be more important in eastern Uganda than man-
to-man transmission. Cattle have been demonstrated to be an important reservoir of
rhodesiense sleeping sickness and therefore, may play a major role in its spread
(Onyango et al., 1965; Maudlin et al., 1990; Hide & Tait, 1991; Hide et al., 1994).
Using biochemical evidence of the magnitude of the sleeping sickness animal
reservoir in cattle and from blood meal analyses, Maudlin et al. (1990) estimated that
tsetse are 500 times more likely to feed on cattle than man (Hide et al., 1996).
Therefore, control by mass treatment of the animal reservoir may be a cost-effective
measure in stopping the transmission of sleeping sickness. Selective treatment of
livestock using trypanocides based on parasitological results was used but now there
is evidence for the poor sensitivity of parasitological methods (Picozzi et al., 2002)
indicating that block treatment of cattle in instances of low parasitological prevalence
by microscopy may be more beneficial. It is quite probable that block treatment
would lead to longer disease free periods since the presence of the vector without the
parasite would not result in transmission.
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In conclusion, spatial clustering was characteristic of sleeping sickness occurrence in
Tororo and Busia districts between 1987 and 2001, presenting an opportunity for
targeted application of sleeping sickness control measures. Tsetse control
interventions reduced the duration of persistence of sleeping sickness clusters where
it was applied, but was often put in place after the development of significant
clustering indicating the need for more timely responsive action. Sleeping sickness
recurred in the same areas after the cessation of donor supported control and
therefore there appears to be donor dependency of sleeping sickness control,
probably because the current traditional approaches are expensive. A timely
responsive, parasite targeted, sustainable strategy is therefore recommended. Ways
of improving case detection and treatment and involving communities were
examined in Chapters 4 and 5. The risk factors for the spatial distribution of sleeping
sickness villages and clusters are examined in Chapter 7.
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Chapter 7 Remote sensing as a surveillance tool to identify
villages at high risk for sleeping sickness
7.1 Summary
Sleeping sickness is a vector-borne disease whose distribution is highly influenced
by tsetse habitat and availability of mammalian hosts. Geographic information
systems (GIS) and remote sensing were used to identify villages at high risk for
sleeping sickness as defined by reported incidence. Landsat Thematic Mapper ™
satellite data were digitally processed to obtain a map of land cover, and a tasseled
cap transformation (Tcap) carried out to determine indices of wetness and greenness.
GIS functions were used to determine the areas of land cover types and average
wetness and greenness within 2 km radii of 747 villages where sleeping sickness
incidence had been calculated. The relationships between sleeping sickness presence
and absence and land cover types or Tcap indices for greenness and wetness were
examined using backward binary logistic regression. The analysis found proximity to
wetlands, low population density, more wetness more cropland and less grassland to
be predictive of sleeping sickness presence with distance to the sleeping sickness
hospital as an important confounder These findings demonstrate the potential of
remote sensing and GIS to characterise village-scale risk of sleeping sickness in
endemic regions. This approach may be particularly useful where sleeping sickness




Sleeping sickness tends to occur focally. Although these foci tend to recur, there is
now evidence of expansion of existing ones (Fevre et al., 2001). For instance, in
eastern Uganda, sleeping sickness is now reported north of the known rhodesiense
focus (Figure 7.1). The movement of infected cattle from areas endemic for sleeping
sickness has been implicated in the cause of this new outbreak in an area where
sleeping sickness was not known to be endemic (Fevre et al., 2001) but where tsetse
were prevalent. These movements of cattle brought the sleeping sickness disease
agent, Trypanosoma brucei rhodesiense, into contact with the vector, Glossina
fuscipes fuscipes. The traditional interventions to control sleeping sickness are case
finding and treatment, tsetse control and treatment of the livestock reservoir of the
disease. In Uganda, these interventions currently being are carried out at sub-national
levels by the national sleeping sickness control programmes supported by the
European Union funded projected "Farming in Tsetse Control Areas of Eastern
Africa (FITCA)". Therefore, to prevent further spread of the disease, it is important
to determine accurately areas of potential risk for effective targeting of disease
prevention efforts.
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Figure 7.1. Map of sleeping sickness endemic districts of Uganda showing the
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Tsetse densities and infection rates are major entomological determinants of sleeping
sickness transmission risk (WHO, 1986). Tsetse maps have not been updated in
recent years. The last tsetse maps of Uganda were produced by Ford and Katondo in
1970 (Gouteux, 1990). Tsetse distribution maps, though very necessary to delineate
areas of potential risk, are expensive to produce through ground-based approaches of
vector surveys. G. f. fuscipes is a riverine tsetse species whose distribution and
density varies with vegetation composition, as it relates to habitat suitability (Baldry,
1980). For example, riverine areas that have been depleted of trees and shrubs do not
provide favourable environments for survival of tsetse and their larvae. Similarly, the
absence of ungulate hosts may not favour the presence of tsetse. These relationships
mean that where sleeping sickness is endemic, land cover typology may be a useful
indicator of sleeping sickness risk in villages.
Land cover and vegetation indices can be mapped over large areas using remotely
sensed data to provide an integrated picture of the distribution that is often difficult
to appreciate from the ground. Land cover corresponds to a bio-physical description
of the earth's surface. It is that which overlays or currently covers the ground. This
description allows bio-physical categories to be distinguished e.g. areas of
vegetation, bare soil, hard surfaces and wet areas. Previous studies have used
satellite-based remote sensing data and geographic information systems (GIS) to
identify and map vector-borne and other diseases' habitats for rift valley fever, tick
borne encephalitis, schistosomiasis and helminth infections (Linthicum, 1987; Daniel
& Kolar, 1990; Hugh-Jones, 1989; Hugh-Jones et al., 1992; Pope et al., 1992; Abdel-
Rahman et al., 1997; Brooker et al., 2000a; Brooker et al., 2002). There have been
some studies exploring remotely sensed environmental factors that may be associated
with tsetse and trypanosomiasis distribution (Rogers, 1991; Rogers & Randolph,
1991; Rogers & Williams, 1993; Kitron et al., 1996; Robinson et al., 1997). Rogers
& Randolph (1991) have shown that the distribution and abundance of tsetse flies
can be related to Normalised Difference Vegetation Indices (NDVIs) (Tucker et al.,
1985). The NDVI is one of the most common vegetation indices derived from
remotely sensed data and is computed by the product of two electromagnetic
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wavelengths (near infrared)/near infrared + red. Maps showing the vegetation of
Africa (Tucker et al., 1985) have been produced using NDVIs. Certain land cover
types may be of greater public health importance due to activities of man and
abundance of tsetse per se may not necessary mean potential human-vector contact.
Therefore, the use of disease distribution as an outcome in the studies of remote
sensed data may provide additional information to what is obtainable from tsetse
distribution.
Remote sensed data is obtained from satellite images. The Landsat satellite uses a
thematic mapping tool to collect electromagnetic radiation reflected off the surface of
the earth, hence its name, Landsat Thematic Mapper ™
(http://landsat.gsfc.nasa.gov). The most recent satellite, Landsat 7, was launched on
the 15th April 1999 and uses an enhanced thematic mapper (ETM). The thematic
mapper collects the data separately but simultaneously in 9 wavelength bands for
discrimination of landscape features allowing for categorisation of land into its use.
There are two techniques that can be used to achieve this function. They are called
the unsupervised and the supervised land classifications (ERDAS Field Guide,
1995). In unsupervised land classification, the software e.g. ERDAS Imagine
(ERDAS Field Guide, 1995) selects the classes on its own while in supervised
classification, the user guides image processing software in selecting classes.
Supervised classification is carried out on an unsupervised classified image.
Tasseled cap transformation is another method of enhancing spectral information
content of Landsat ™ data (Lillesand & Kiefer, 1987). The tasseled cap index relates
TM bands (1-5 and 7) to measures of vegetation (greenness), soil (brightness) and
the relationship of soil and canopy moisture wetness.
Landsat Thematic Mapper data have a spatial resolution of 28.5m x 28.5m in most
bands and therefore these data may be useful in characterising differences in key land
cover and spectral indices differences among and within villages that are associated
with highly local patterns in vector distribution and disease risk. If such differences
could be observed, they might also be used to distinguish high from low risk villages
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then this remote sensing/GIS approach could provide a means for detailed mapping
of sleeping sickness areas within the districts.
150
7.3 Materials and methods
7.3.1 Study area
The study area was Tororo and Busia districts in eastern Uganda (Figure 7.1) that
was within the area covered by the Landsat image used in the analysis (Section
7.3.3.1). They were 747 census villages that met this criterion each with an area of
approximately 0.5 to 5 sq.km. Within the study area, many wetlands drain into Lakes
Kyoga and Victoria. The climate has two distinct wet (September to November and
March to May) and dry (June to August and December to February) seasons. There is
growing land pressure with people encroaching on the swamps. The riverine species
G.f fuscipes is considered to be the main vector for sleeping sickness (Okoth, 1986).
The human population belongs to four main ethnic groups; the Adhola, Teso, Samia
and Nyole. There are mainly rural mixed farmers, growing subsistence crops and
rearing small holdings of cattle.
7.3.2 Data collection
Central positions in settlements in villages were selected and geo-referenced using a
geographical positioning system (GPS) by Garmin No. 12. Sleeping sickness data for
all these villages for the years 1987 to 2001 were obtained from the Ministry of
Health. The case data analysed in this study were obtained from the records of three
treatment centres: LIRI Hospital, Lumino Health Centre and Busolwe Hospital.
Populations of the villages were obtained from the 1991 national population census
and projected by a population growth rate of 2.5% to the 1998 population. Wetland
maps were obtained from the Ministry ofNatural resources, Wetlands division.
7.3.3 Processing of satellite image
7.3.3.1 Satellite data preparation
The satellite image was processed using ERDAS Imagine version 8.4 and Arc View
GIS version 3.2. The scene used was from the Landsat Enhanced Thematic Mapper
(ETM), series 7 taken on the 13th February 2001, at day time, cloud cover 9%,
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datum option WGS 84, map projection UTM zone 36S and geotiff format. The image
comprised 9 spectral bands: 6 infra-red (resolution 28.5 m x 28.5 m); 2 thermal
(resolution 57 m x 57 m); 1 panchromatic (resolution 14.25 m x 14.25 m). The image
was exported from ERDAS to ArcView GIS in Tiff format. Individual bands were
converted to grids using a nearest neighbour re-sampling technique with a pixel size
of 14.25 m x 14.25 m used for all bands and images maintained in the Tiff format.
The image was re-imported into ERDAS and reconstructed as a multi-band image
before re-exporting it back to Arc View GIS for warping.
The ArcView GIS Image Warp function was used to compare ground control points
(GCPs) of 1999 topographic maps at a 1:50,000 scale. Topographic maps obtained
from the Uganda department of Lands and Surveys were digitally scanned and saved
in JPEG files and re-projected to satellite image projection. Scanning distortions
were corrected using 8 ground control points (GCPs) (grid line intersections) read off
the map and typed into Image Warp programme. Second order polynomial fit was
used to correct scanning errors. Scanned and geo-registered maps were used to geo-
rectify the Landsat image using clearly defined points on the image e.g., road
intersections that could be located on the topographic maps. Of 45 candidate GCPs,
15 were retained in the model used to rectify the image using a third order
polynomial. The Error Root Mean Squares (RMS) were: X error of 4.49 and Y error
of 4.71 which were good because they were less than the pixel size of 14.25 m. The
satellite image was then suitable for classification
7.3.3.2 Land cover determination
Unsupervised classification was performed using ERDAS Imagine. This process
creates thematic raster layers by letting the software identify statistical patterns in the
multi-spectral data without using ground truth data. The ISODATA algorithm was
used to create 20 classes. This is a clustering method that uses a minimal spectral
distance formula to form clusters using arbitrary cluster means. The programme
iterates until a maximum number of iterations or maximum number of unchanged
pixels has been reached between iterations. Six iterations and a 95% convergence
threshold were used.
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185 ground truth points that were within continuous (more than 16 pixels) and
therefore homogenous areas of the class were selected for ground truthing to explain
the meaning of the classes in the unsupervised classification. Classes 1 and 2 (water)
were excluded because they were very clearly identifiable. Each point was visited
and described according to a land cover classification of water, shallow swamp, deep
swamp, natural forest, riverine forest, shrub, cropland, short grassland and long and
dense grassland. Variations within a land cover class type were also noted where
they were clear intra-class differences. Positions of points within swamps were
viewed from a distance. All these data were entered into a database. These ground
truthed points were then used to carry out a supervised classification that was used in
the analysis by providing signatures to guide ERDAS Imagine in classifying the land
cover.
7.3.3.3 Tasseled cap transformation
Tasseled Cap transformation (Tcap) offers an alternative way to optimise data
visualisation for vegetation studies (Lillesand & Kiefer, 1987). Tcap values were
derived by transforming the unsupervised classified Landsat TM satellite image.
Tcap is based on three data axes, which define the three components of vegetation
characteristics (Crist et al., 1986, Crist & Kauth, 1986): Brightness is a weighted sum
of all bands, defined in the direction of the principal variation in soil reflectance;
Greenness is orthogonal to brightness, a contrast between the near-infrared and
visible bands that is strongly correlated to the amount of green vegetation in the
scene; and Wetness relates to canopy and soil moisture (Lillesand & Kiefer, 1987). A
simple calculation (linear combination) then rotates the data space to present the axes
to the user.
To determine whether Tcap values are statistically related to incidence rates at the
747 villages during the 15 year period, Tcap values were calculated using data from
all Landsat channels to produce wetness, greenness and brightness (dryness) indices;
each pixel being assigned a vector value based on variable proportions of signals for
each of these three indices (ERDAS Field Guide, 1995).
153
7.3.4 Spatial data extraction
The database file of villages was converted in ArcView into a shapefile and then
converted into a raster file using ArcView Spatial Analyst. Shapefiles are the GIS
data in a vector format i.e. points lines or polygons. For purposes of data extraction,
the shapefiles were converted into grid formats (i.e. pixel data) for compatibility with
ArcView GIS analysis functions. ArcView GIS was used to quantify the areas of
each land cover class surrounding each village. It generated polygons (i.e. buffers)
extending 2 km from a village central point for each of the 747 villages; these buffers
were then overlaid on the Landsat TM-derived supervised classification image to
calculate the area of each landuse cover class surrounding each village. Two km was
chosen because it has been reported that G. f fuscipes makes a linear advance on
average of only 20 m a day (Williams et al., 1992) while it is estimated that a rural
farmer would travel typically less than one km away from his home to his farmland,
grazing land, or to collect firewood or water because homes were in villages of less
than 5 sq. km. The buffers were also overlaid on the Tcap images for wetness and
greenness to calculate the mean, median and standard deviation of each spectral
index for each buffer area. Brightness was excluded because this measure includes
reflectance from roofs and roads, which were not of interest in this study. The
outputs of the ArcView GIS functions were exported into Microsoft Excel. The
number of sleeping sickness cases by village and the distance of villages from the
sleeping sickness hospital determined by Arc View GIS were added to the set (Figure
7.2). Parish population densities (MOF, 1992) were included as well as distances
from wetlands as determined by ArcView GIS.
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Figure 7.2. Map of the unsupervised classified image with the parish boundary map
of Tororo and Busia districts superimposed.





























Figure 7.3. Map of a subset of village points used to construct 2 km buffers from
which proportions of each land cover class type and means of greenness and wetness
were extracted.
The position of the sleeping sickness hospital and the 10 km radius around it are also
shown. This is a supervised land cover classified image.
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Figure 7.4. Map showing parish population densities and distribution of reported
sleeping sickness presence and absence in villages in Tororo and Busia district,
eastern Uganda, 1987-2001.
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Figure 7.5. Map showing distance to wetlands and distribution of reported sleeping
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7.3.5 Data analysis
Data was initially handled in Microsoft Excel and SPSS software to calculate
numbers of infected villages using the sleeping sickness case reports for the years
1987 to 2001. Areas of the different land cover class types within 2 km of the GPS
position were used in the analysis. For Tcap variables, mean wetness and mean
greenness values were used. Although the values for mode and median wetness and
greenness were available, means were chosen because there were little differences
between them indicating that the values were normally distributed. Land cover class
cover types and Tcap variables were analysed in separate models because they were
derived from the same unsupervised classified image. Other variables included in the
analyses were parish population density of the village, altitude, and distance from the
sleeping sickness hospital and from the major wetlands. Using the outcome of
presence and absence of sleeping sickness, univariate analyses followed by binary
logistic backward regression analysis of variables with associations of significance of
P <0.20 (Maldonado & Greenland, 1993a,b) was carried out. Variables were
removed from the logistic equations until removal of none of the remaining variables
significantly improved the prediction of presence or absence of sleeping sickness (i.e.
the fit of the model).
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7.4 Results
7.4.1 Sleeping sickness data
A total of 1,316 sleeping sickness cases were reported during the study period
January 1987 to December 2001. Out of 747 villages, 285 of the villages reported at
least one case while 462 did not report any cases. The annual incidence of sleeping
sickness from 1987 to 2001 in the villages ranged from 0 to 35 per 10,000 people.
7.4.2. Unsupervised classification
The resultant image after a 20 classes unsupervised classification of the Landsat
image is shown in Figure 7.1. Classes 1 and 2 were clearly open water and it was
difficult to distinguish between forest and swamp in the unsupervised classified
image because they had the same reflectance.
7.4.3. Tasseled cap transformation
The results of the means and standard deviations of mean wetness and mean
greenness indices obtained after tasseled cap transformation of the Landsat image are
shown in Table 7.1. The mean wetness index was 177.7 within the positive villages
and 176.4 within the negative villages while the mean greenness index was 149.4
within the positive villages and 148.7 within the negative villages indicating that
positive villages had more thick green vegetation than negative villages.
7.4.4. Supervised classification
Ten land cover types were distinguished: Open water, shallow swamp, deep swamp,
natural forest, riverine forest, open shrub, dense shrub, cropland, long and dense
grassland and short grassland (Figure 7.2). The general distribution of villages that
reported and those that did not in relation to the supervised land cover classes is
shown in Figure 7.2 The results of the means and standard deviations of the areas of
supervised land cover types are shown in Table 7.1.
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Table 7.1. Univariate analysis of prediction of presence/absence sleeping sickness
(1987-2001) by land cover and tasseled cap (Tcap) variables of 747 villages in
Tororo and Busia districts, eastern Uganda.
Variable Present Absent P value
n= 285 n= 462
mean + SD mean + SD
Crop (sq.m) 504.6 + 14.5 489.5 + 9.8 <0.001
Long & dense grass (sq.m) 72.2 + 4.8 83.1 + 3.6 0.06
Dense shrub (sq.m) 190.0 + 6.6 182.5 + 6.0 0.42
Deep swamp (sq.m) 14.4 + 2.0 9.5 + 1.2 0.02
Natural forest (sq.m) 31.9 + 3.1 27.0 + 2.8 0.26
Short grass (sq.m) 142.2 + 9.1 164.4 + 7.4 0.06
Open shrub (sq.m) 257.6 + 12.9 267.7 + 10.0 0.53
Riverine forest (sq.m) 15.7 ± 1.0 13.1 + 0.7 0.03
Shallow swamp (sq.m) 17.8 + 2.8 11.1 + 1.3 0.02
Open water (sq.m) 3.5 + 2.2 1.4 ± 0.8 0.29
Distance from hospital - - <0.001
Distance from wetlands (km) 0.5 + 0.5 1.1 + 1.0 <0.001
Parish population density 302.8 + 22.1 516.7 + 36.7 <0.01
Wetness index 177.7 + 0.3 176.4 + 0.3 <0.001
Greenness index 149.9 + 0.4 148.7 + 0.3 <0.001
Altitude 1178.0 + 4.0 1186.0 + 3.0 0.08
Distance from
cattle markets (km) 7.4 + 4.0 7.5 + 4.6 0.93
SD = Standard Deviation, n = number of villages
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7.4.5. Regression analysis results
The results of the univariate analysis of the relationship of presence and absence of
sleeping sickness to different land cover types and Tcap variables are shown in Table
7.1. Univariate analysis of each factor revealed that deep and shallow swamp,
riverine forest, long and short grasslands population density, distance from wetlands,
altitude and wetness were correlated with sleeping sickness presence or absence at a
significance level of P<0.20. None of the other investigated variables showed an
independent correlation with sleeping sickness presence or absence. After binary
logistic regression of the land cover types, short grassland, distance to the wetlands
and hospital remained significant (P<0.05) in the model while in the Tcap values
model, wetness, distance to wetlands and to hospital and population density remained
significant (P<0.05) in the equation. The estimated coefficients and standard errors
of the landuse cover type model is shown in Table 7.2 while that of the Tcap model
is shown in Table 7.5. The goodness of fit of the landuse cover type model is shown
in Table 7.3 and that for the Tcap model in Table 7.6. Therefore, the relationships
may be modelled as follows:
Probability of sleeping sickness in a village = 1/(1+e"z),
where for the land cover model,
Z= 2.315-(Distance to hospital x 1,034)-(Population density x 0.001)-(Distance to
wetlands x 0.001)-(short grassland x 0.000l)+(cropland x 0.0001).
and for the Tcap model,
Z= -3.006-(Distance to hospital x 1.006)-(Population density x 0.001)-(Distance to
wetlands x 0.001)+(wetness x 0.031)
The land cover model correctly predicted 81.2% of sleeping sickness negative
villages and 46.3% of the sleeping sickness positive villages (Table 7.4). There was
67.9% overall prediction of sleeping sickness presence and absence in villages in
Tororo and Busia between 1987 and 2001. The Tcap model correctly predicted
79.2% of sleeping sickness negative villages and 44.9% of the sleeping sickness
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positive villages (Table 7.7). There was 66.1% overall prediction of sleeping
sickness presence and absence in villages.
The relationship between population density and reported sleeping sickness reported
presence or absence in the 747 villages is shown in Figure 7.3. There is a negative
relationship between population density and sleeping sickness presence with sleeping
sickness being more prevalent in low population density villages. The relationship
between distance from wetlands and reported sleeping sickness distribution is shown
in Figure 7.4. There is a negative relationship between distance to wetlands and
sleeping sickness presence with a lesser proportion of positive villages further away
from the wetlands.
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Table 7.2. Coefficients of a logistic binary model predicting the presence and
absence of sleeping sickness (SS) in different villages of Tororo and Busia districts,
using observed disease data and land cover variables
Variable B SE Wald df P Exp(B)
Population -0.001 0.000 21.233 1 <0.0001 0.999
density
Distance from -0.001 0.000 47.377 1 <0.0001 0.999
wetlands
Distance from - 1.034 0.257 16.191 1 <0.0001 0.356
hospital
Cropland <0.0001 0.000 4.572 1 0.033 1.000
Short grass <0.0001 0.000 5.627 1 0.018 1.000
Constant 2.315 0.561 17.012 1 <0.0001 10.121
df= degree of freedom; SE = standard error; P = significance, B = coefficient
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Table 7.3. Goodness of fit of a logistic binary model predicting presence and
absence of sleeping sickness (SS) in different villages of Tororo and Busia districts
using observed disease data and land cover variables
Variable Model Change in df Significance of
Log -2 log likelihood change
Likelihood
Population density -441.101 31.512 1 <0.0001
Distance from wetlands -461.914 73.139 1 <0.0001
Distance from hospital -433.884 17.078 1 <0.0001
Short grassland -428.270 5.851 1 0.016
Cropland -427.637 4.584 1 0.032
df = degree of freedom
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Table 7.4. Percentages of correct predictions of presence and absence of sleeping
sickness (SS) in different villages in Tororo and Busia districts using disease data
and land cover variables
Predicted SS
Observed SS Absent Present Correct prediction
(%)
Absent 375 87 81.2
Present 153 132 46.3
Overall 67.9
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Table 7.5. Coefficients of a logistic binary model predicting the presence and
absence of sleeping sickness (SS) in different villages of Tororo and Busia districts,
using observed disease data and Tcap variables
Variable B SE Wald df P Exp(B)
Distance -1.006 0.245 16.862 1 <0.0001 0.366
to hospital
Population -0.001 0.000 19.334 1 <0.0001 0.999
density
Distance from -0.001 0.000 45.462 1 <0.0001 0.999
Wetlands
Wetness 0.031 0.016 3.724 1 0.054 1.031
Constant -3.006 2.816 1.140 1 0.286 0.049
df = degree of freedom; SE = standard error; P = significance
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Table 7.6. Goodness of fit of a logistic binary model predicting presence and
absence of sleeping sickness (SS) in different villages of Tororo and Busia districts
using observed disease data and Tcap variables
Variable Model Change in df Significance of
Log likelihood -2 log change
likelihood
Distance to hospital -436.883 17.712 1 <0.0001
Population density -442.604 29.155 1 <0.0001
Distance from -462.513 68.972 1 <0.0001
wetlands
Wetness -429.918 3.783 1 <0.052
df = degree of freedom
168
Table 1.1. Percentages of correct predictions of presence and absence of sleeping
sickness (SS) in different villages in Tororo and Busia districts using disease data
and Tcap variables
Predicted SS
Observed SS Absent Present Correct
prediction (%)
Absent 366 96 79.2




Sleeping sickness can be described as an ecological disease because certain habitat
factors affect its distribution. Athough the eco-epidemiology of sleeping sickness has
long been known, there have been few attempts to map sleeping sickness in relation
to land cover and vegetation indices. The identification of eco-epidemiological risk
factors for sleeping sickness would allow sleeping sickness control programmes to
prioritise areas for intervention.
This is the first study of its kind presenting a detailed analysis of village distribution
in relationship to eco-epidemiological factors in Tororo and Busia districts. The
study showed that in G. f. fuscipes infested rhodesiense sleeping sickness endemic
areas, sleeping sickness presence or absence is associated with distance to wetlands,
population density, short grass, cropland, wetness of vegetation and distance to the
sleeping sickness hospital.
The association of sleeping sickness presence to the Tcap wetness index and distance
from wetlands is in agreement with field-based studies of the landscape ecology of
the palpalis group of tsetse (Jackson, 1945). The risk association observed with
cropland is because cultivation involves the intrusion into tsetse habitats when
clearing overgrown bush in either land left unattended since the last growing season,
fallow land or new gardens. The population of Uganda is increasing at an average
rate of 2.5% per annum (MOF, 1992). An inverse relationship between the incidence
rate for sleeping sickness and population density by parish was observed and
suggests that this increment in population may result in the destruction of the tsetse
habitat and eventual reduction of sleeping sickness. The study provides further
evidence of the association between population pressure and sleeping sickness with
populated areas being less at risk most probably due to destruction of the tsetse
habitat. Reid et al. (1997a,b) predicted changes in the distribution of G. morsitans
and G. fusca over the next 50 years while Morris (1951) observed that a reduction of
tsetse habitat especially by the removal of riverine forest, could bring about a
sustained reduction in the risk of human infection. Related to reduction of bush and
other dense vegetation, is the finding of a significant relationship between a larger
area in a village of short grassland and absence of sleeping sickness.
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It is possible that these variables influence the populations of tsetse and the reservoir
hosts of T. b. rhodesiense. The analysis used patient data from the sleeping sickness
treatment centres. There may be limitations with using sleeping sickness reported
incidence to determine risk maps compared to using tsetse surveys. Under-detection
of sleeping sickness is acknowledged and may result in misclassification of some
villages. In Chapter 4, significant association was shown between both sleeping
sickness incidence and the proportion of early cases to distance from the sleeping
sickness hospital in this area. This demonstrated the decrease in sensitivity of
surveillance beyond 10 km from the hospital. It is for this reason that the distance
from the sleeping sickness hospital was included in the analysis, that is, to adjust for
spatial effects of under-detection.
The satellite derived map of land cover shows heterogeneity in the distribution of
land cover classes in the study area ranging from forests and shrub land, through
farmed land, and grassland, to swamps and open water. These land cover classes
surrounding villages change considerably within a few kilometres (Figure 7.3).
Although land cover types may be appreciable by the eye in very small areas,
variations over wider areas cannot and therefore, remote sensing and GIS functions
present powerful means of revealing areas of sleeping sickness risk and thus of
priority for surveillance and control. These results can be used to estimate risk in
areas where reporting is likely to be low or where surveys cannot be easily carried
out. The remote sensed risk factors could be combined with other variables to aid
decision support for intervention. Such variables can include population, poverty,
access to health services and of distribution of cattle. It can also be used to monitor
changing risks resulting from changing land cover distributions.
This study focused on identifying variation in landuse cover and Tcap indices that
may be associated with village-level disease risk. However, within the villages,
homesteads most affected with sleeping sickness may be more closely associated
with particular risk factors than in other areas of the village indicating the possible
need for further accuracy in application of control options at a scale greater than the
village. The vegetation indices used are easy to generate since the necessary
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computer software is now increasingly available. Land cover and vegetation indices
maps can be combined with sleeping sickness disease distribution maps to target
high risk villages and assist the direction of public health resources to where they are
most needed.
In conclusion, these results demonstrate that villages with high sleeping sickness risk
can be identified by using remote sensing and GIS technologies. Distance to
wetlands and population density are certainly the most important predictors and are
readily available from maps and national human population censuses. The specific
finding that sleeping sickness risk at village scale is related to the wetness index may
be applicable to other areas where riverine tsetse species are vectors for sleeping
sickness. In areas were the disease vector is present but the disease is not, this
approach could provide a map of potential risk; that is, where vector-human contact
is high and transmission would be significant given the introduction of infection.
This approach will provide an important tool for disease surveillance programmes in
that it enables localised assessment of risk based on geographic elements associated
with high sleeping sickness risk. Remote sensing and GIS can therefore be used to
more efficiently direct case finding as well as to focus control strategies, thus
reducing costs.
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Chapter 8 General Discussion
In this chapter the salient findings with respect to the six original objectives are
discussed and the study design reviewed. Subsequently, the next section of the
general discussion outlines the implications of the research for sleeping sickness
control. Finally, implications for future research both on surveillance of disease and
in particular, on the application of Geographical Information Systems are discussed
8.1 Development and application of epidemiological surveillance tools
for rhodesiense sleeping sickness
In Chapter 2, an objective method for the estimation of under-detection of
rhodesiense sleeping sickness has been developed. The method takes into account the
clinical progression of the disease in that a sleeping sickness patient progresses from
the early to late stage and subsequently succumbs to the disease. It assumes that
death during the early stage is minimal when compared to that during the late stage
and it uses estimates of duration of symptoms to death and to late stage from
empirical data to determine competing rates of progression to these two outcomes.
The finding of a magnitude of twelve times more undetected deaths than those
reported calls for more efforts in improving case finding.
The burden of sleeping sickness in an outbreak situation was determined in Chapter 3
and provides a mechanism for ranking the importance of the disease when compared
to other diseases in the same affected communities. It uses DALYs that are standard
measures for burden of disease used by WHO and the World Bank but not often
applied at levels where decisions are taken. Taking into account the level of under-
detection as estimated in Chapter 2, demonstrates the importance of under-detection
quantification in determination of disease burden. The burden estimation also
describes the direct effect on the health services, an element often neglected in the
ranking of disease. The estimation of burden in our study applies a model that was
derived in this study. Sensitivity analysis revealed that the model is robust and
therefore estimates of under-detection for use in the estimation of burden of sleeping
sickness can be relied upon.
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A significant association between the proportion of late stage patients and increasing
distance from the health unit as well as the annual parish incidence was demonstrated
in Chapter 4. GIS functions were used to estimate the distance in 10 km ranges of
travelling to the reporting sleeping sickness treatment centre. Euclidean distance
estimates are adequate for this purpose since most patients travel by bicycle or on
foot. Annual parish incidences were used in the analysis as opposed to annual
incidences for the whole area, with the expectation that high sleeping sickness
incidence would increase awareness among the immediately affected population and
thus early case detection.
In Chapter 5, delays in diagnosis were shown to be mainly due to missed diagnosis
or inability to diagnose sleeping sickness as well as a result of poor socio-economic
status. Importantly, service provider delay was quite significant in explaining late
stage presentation. Definitions of service provider delay were based on the first
contact with a recognised health worker to final diagnosis because the challenge to
make a substantive diagnosis is the onus of the health worker who may cause further
delay if he/she does not refer the patient. Many of the extra deaths quantified in
Chapter 2 take place despite patients having already reported to the health care
system.
In Chapter 6, there was significant spatial temporal clustering observed over the
entire period, indicating that spread of infection can be contained by timely and
effective control. Part of the spatial temporal trends of sleeping sickness observed
could have been due to control measures that were in place. Despite application of
control, there were villages that continued to report sleeping sickness annually for
greater than one year and there is now evidence of resurgence of the disease in the
study area. This further emphasises the need for timely application of control
measures that should be targeted where the disease is reported. These methods
should be sustainable after cessation of donor funding.
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Land cover classification and tasseled cap transformation of a Landsat satellite image
in Chapter 7 revealed associations with distance to wetlands, population density,
cropland, short grassland and vegetation indices, providing an important way for
discriminating sleeping sickness risk villages. Village shapes are not necessarily
circular and equal and therefore our methodology does introduce some degree of
error. However, the village points were checked for inclusion in the right parishes as
per available polygonal parish boundary maps obtained from the National Biomass
Study Project (MONR, Uganda, 1996). Therefore, the accuracy of the areas
described was adequate for the purposes of the study.
The application of GIS to improve disease surveillance has its limitations. Control
efforts may confound the association of the distribution of trypanosomiasis to the
existence of tsetse habitat (Robinson et al., 1999). In this study the distance to
sleeping sickness hospital was a confounding factor for the endemic status of a
village. There is lack of reliable statistics and under-detection of disease in Africa
because of infra-structural and cost constraints (Snow et al., 1999). As a result,
disease estimates on the continent are often based on clinical and not on a diagnostic
basis. The other problem that exists is the lack of trained technical staff in GIS in
developing countries (Nijkamp & De Jong, 1987; Taylor, 1991). Local scientists who
understand both the socio-economic context and technological aspects in which the
systems will operate will make GIS very useful and effective. The costs of spatial
data are most certainly an impediment of using GIS in some tropical countries
(Briggs & Elliot, 1995).
Although there are quite a number of studies that use GIS in order to understand the
spatial variation of disease to environmental factors, there are only a few that explore
the association between disease distribution and the health care system (Zwarenstein
et al., 1991; Perry & Gessler, 2000; Tanser et al, 2001; Tanser, 2002). In this thesis,
both applications were used.
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8.2 Implications for control of sleeping sickness
Under-detection of sleeping sickness is acknowledged but has never been objectively
estimated. However, in this study, a formula for the estimation of under-detection
and the associated mortality of sleeping sickness is developed. The early to late ratio
is suggested as an epidemiological indicator for under-detection for use by sleeping
sickness surveillance programmes because staging of sleeping sickness patients is a
routine procedure in all sleeping sickness control programmes. It can also be used to
estimate the actual mortality due to sleeping sickness in a community and therefore
the burden of the disease in that community. This was the first attempt at objectively
quantifying the level of under-detection of rhodesiense sleeping sickness. Although,
it is a conservative estimate that assumes no fatality due to early stage disease, it can
be supported by the argument that a significant proportion of the few fatalities in the
early stage are treatment related, e.g. due to exfoliative dermatitis or renal failure.
The estimation of burden of disease using indices such as the DALY should take into
account under-detection. The DALY is a measure that is recommended by the World
Bank and the WHO for use as a criterion in the allocation of resources to health
services. In Uganda, the national programme for the control of sleeping sickness has
been decentralised to the district level and therefore, the planning of allocation of
resources for health services is carried out at the district. The DALY has not been
routinely used for health planning in Uganda. During the last 10 years, only one
national survey of burden of disease in Uganda was conducted in 1994 that was
health unit based and only used mortality statistics. In this study the relative burden
of disease of the top ten diseases in the study districts was determined. Rhodesiense
sleeping sickness featured as the eighth in Iganga district but did not feature in the
other four study districts in the sleeping sickness endemic area (MOH, 1996).
However, this study indicates that sleeping sickness outbreaks often occur in areas
smaller than a district. Such areas and their health units require special attention to
resource allocation for case management and disease control in general. This study is
the first one of its kind that has sought to determine the burden of sleeping sickness
in an outbreak.
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Mapping of the distribution of sleeping sickness cases from the diagnostic centres
indicates that late case detection and thus under-detection is associated to distance
from diagnosis especially beyond 20 km radius emphasising the need for optimising
the distribution of fixed-post diagnosis. There are other health units in the two
districts with the capacity to diagnose sleeping sickness but have not been involved
in the sleeping sickness control programme activities because the health system has
not taken the initiative to involve them. There is also increased early case detection
when there is high disease incidence in a locality most probably associated with
increased awareness. Adults are more likely to be diagnosed in the early stage than
children and adolescents. Sleeping sickness surveillance programmes should bare in
mind these variations in early case detection.
Health service provider delay appears to be an important factor in the causation of
late stage presentation and thus fatality of sleeping sickness. In endemic areas, health
service providers should regularly be reminded of the possibility of sleeping sickness
even when their health units do not treat the disease. The results of this study suggest
that the involvement of the community in referral of sleeping sickness suspects and
generally in the treatment of their livestock and the application of pour-on insecticide
may be an effective entry point for sleeping sickness control. Regular reminding and
updating of health workers in sleeping sickness endemic areas most especially when
there is evidence of sleeping sickness occurrence in the vicinity will most certainly
increase their index of suspicion and improve the early detection of sleeping sickness
cases.
The results of analysis of spatial and temporal trends of rhodesiense sleeping
sickness indicate the need for the creation of a geographically sensitive, timely
responsive health information and intervention system. This would avert the
emergence of outbreaks. Passive case finding and treatment remains the major
control strategy for rhodesiense sleeping sickness. The costs of improving the
information system for passive case finding are minimal when you consider the costs
of active case finding or vector control.
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A cartographic approach to sleeping sickness control allows for delimitation of area
of application of control. In this study it has been shown that GIS can provide an
accurate and powerful means of determining which villages need to be given priority
for application of tsetse traps, pour-on insecticides, block treatment of cattle and
community sensitisation and therefore ensures optimal use of scarce resources.
Whenever an outbreak occurs, its limits and relationship to the existing tsetse habitat
should be described using GIS. Such an approach would not only reduce operation
costs but also prevent expansion of outbreaks.
WHO has put emphasis on improving the performance of health systems and
dedicated the world health report for the year 2000 to this cause. This thesis further
demonstrates the spatial aspect of health systems research. With GIS, health systems
coverage can be analysed spatially and effectively. Therefore, GIS has the potential
to contribute to rational and more cost effective planning and resource allocation in
sub-Saharan Africa.
8.3 Implications for future research on surveillance of sleeping
sickness
There is now little doubt about the need to plan sleeping sickness control in a focal
context. However, further operational research issues still remain. Development of a
model for the estimation of under-detection of T. b. gambiense sleeping sickness can
be carried out using the same procedure outlined in Chapter 2. Estimation of duration
of illness to late stage and death can be carried out in a clinical setting with an
adequate sample size of sleeping sickness patients to account for recall bias. In
Chapter 3, the direct burden of sleeping sickness on the family and community at
large was not determined by examining the impact of absence of family members
either due to being affected by sleeping sickness or due to taking care of the sick
when they are admitted. To quantify the potential contribution of other health units
that are not currently involved in sleeping sickness surveillance, these units should be
mapped out and their distribution compared with the current distribution of sleeping
sickness. In this way, planning of the distribution of new sleeping sickness centres
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can be rationally carried out. A patient-based health information system for sleeping
sickness is recommended in Chapter 5. Such a system should be evaluated for its
effect on early case presentation. There are questions on how to involve the
immediately affected communities in control of the disease. Can a systematic referral
system of sleeping sickness suspects be initiated at the sleeping sickness health units
whereby the affected families are used to alert and bring other sick people for
testing? Are there ways of involving all health units into sleeping sickness diagnosis
and sometimes treatment? Within the most recent significant sleeping sickness
clusters identified in Chapter 6, information should be sought on the source and
movements of cattle to investigate the possible sources of infection. When data for
cattle census is available, cattle population densities should be included in the model
in Chapter 7 since they are known to be important mammalian hosts in this
environment. Village scale resolution was used in the studies of Chapter 6 and 7, but
more information may be obtained through homestead geo-referencing, as it appears
that even within a village, sleeping sickness cases may be focalised. The
investigation of associations with land cover and disease distribution would then
require maps at a resolution of aerial photography to decipher differences in
vegetation cover in small areas. Mechanisms for sharing the information with and
ensuring action by actors responsible for vector control and treatment of the domestic
animal reservoir need to be researched. Currently, vector control and mass treatment
of livestock are a mandate of the Ministry of Agriculture while case finding and
treatment of patients is for the Ministry of Health. This means that even funding of
activities has taken a sectoral approach. Mechanisms of funding of activities of the
Ministry of Agriculture by budgets from the Ministry of Health should be researched
and advocated. In addition, a framework should be designed for integration of




The key lessons learnt from this study are as follows:
> The early to late stage ratio is a useful tool for surveillance of sleeping
sickness;
> Sleeping sickness burden to the community and health services can be
overwhelming during outbreaks even with relatively few reported sleeping
sickness cases;
> The optimal distribution of fixed-post diagnosis surveillance structures will
greatly improve surveillance of rhodesiense sleeping sickness;
> Patient and service provider delays are both important in the causation of late
stage presentation of sleeping sickness cases with the latter contributing to
most of the delay;
> Involvement of communities in sleeping sickness surveillance and control
appears to be an effective entry point for control programmes;
> Remote sensing can be used to chararacterise sleeping sickness village scale
risk;
> Sleeping sickness can be controlled by timely responsive surveillance and
control targeted using GIS.
The overall goal of this work was to develop and apply epidemiological surveillance
tools for surveillance and control of sleeping sickness. This goal has been achieved
through use of the early to late ratio to develop a decision tree model and through the
application of this model to data from Serere and Tororo and Busia to determine the
burden and the spatial and temporal distribution of under-detection of rhodesiense
sleeping sickness. In addition, using GIS as a tool, evidence for the optimization of
the distribution of sleeping sickness health facilities has been demonstrated as a
potential risk factor for improving early case detection, and village-scale timely
implementation of surveillance and control has been shown to be an important
strategy for control. These findings suggest that the surveillance can be improved by
timely sensitization of the affected communities and the primary health care service
providers. Costs of control can also be reduced by reducing the geographical area of
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Appendix
Questionnaire on health-seeking behaviour of sleeping sickness cases












Socio-demographic variables of patients
Educational status: Secondary and above (1), Primary (2), None (3)
Unable to read English: Yes (1), No (2)
Living house: Hut (1), Semi-permanent (2), Permanent (3)
Ethnicity: Adhola (1), Teso (2), Samia (3), Nyole (4), Other (5)
Marital status: Married (1), Not married (2)
Religion: Catholic (1), Protestant (2), Muslim (3), Other (4)
Work: Employed (1), Not employed (2)
Radio: Yes(l), No (2)
Bicycle: Yes(l), No (2)
Cows: Yes (1), No (2)
Symptoms among patients
Headache: Yes (1), No (2)
Fever: Yes (1), No (2)
General body aches: Yes (1), No (2)
Weakness: Yes (1), No (2)
Loss ofweight: Yes (1), No (2)
Chancre: Yes (1), No (2)
Swelling of feet: Yes (1), No (2)
Dizziness: Yes (1), No (2)
Knowledge and perceptions of patients
Kind of disease patient thought: Malaria (1), AIDS (2), TB (3), Bewitched (4), Other
(5)
Origin of disease: Tsetse fly bite (1), Other (2)
Aware of livestock reservoir for sleeping sickness: Yes (1), No (2)
Aware of use of live bait technology for tsetse control: Yes (1), No (2)
Aware of the use of traps for tsetse control: Yes (1), No (2)
Aware of nearest sleeping sickness treatment centre: Yes (1), No (2)
Seen a sleeping sickness case before: Yes (1), No (2)
Utilisation of health and veterinary services
Type of health facility first approached for help:
Private clinic (1), Health centre (2), Hospital (3) Traditional Healer (4),
Outreach (5)
Attended sleeping sickness outreach activities: Yes (1), No (2), Not applicable (3)
II


















Referred to sleeping sickness hospital: Yes(l), No (2)
Time from the onset of symptoms to first visit to health unit
Upto 2 weeks (1)
>2 weeks to one month (2)
>One month to two months (3)
>Two months to three months (4)
>Three months to four months (5)
More than 4 months (6)
Time between first visit to a health unit and diagnosis for sleeping
sickness
Upto 2 weeks (1)
>2 weeks to one month (2)
>One month to two months (3)
>Two months to three months (4)
>Three months to four months (5)
More than 4 months (6)
Duration of symptoms before sleeping sickness diagnosis ( ):
Upto 2 weeks (1)
>2 weeks to one month (2)
>One month to two months (3)
>Two months to three months (4)
>Three months to four months (5)
More than 4 months (6)
Reasons reported for delayed diagnosis for sleeping sickness:
III
Lack ofmoney (1)
Lack of correct diagnosis (2)
Illness considered mild (3)
Other reasons (4)
Treats cows for nagana: Yes (1), No (2), Not applicable (3)
Uses live bait technology: Yes (1), No (2)
Traps are deployed in village: Yes (1), No (2)
